{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:33:28Z","timestamp":1790256808117,"version":"4.1.0"},"reference-count":354,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T00:00:00Z","timestamp":1245974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00262-009-0728-1","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T08:56:21Z","timestamp":1245920181000},"page":"1723-1747","source":"Crossref","is-referenced-by-count":176,"title":["On the origin of serum CD26 and its altered concentration in cancer patients"],"prefix":"10.1007","volume":"58","author":[{"given":"Oscar J.","family":"Cordero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,6,26]]},"reference":[{"issue":"12","key":"728_CR1","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1177\/37.12.2573631","volume":"37","author":"WN Dinjens","year":"1989","unstructured":"Dinjens WN et al (1989) Distribution of adenosine deaminase complexing protein (ADCP) in human tissues. J Histochem Cytochem 37(12):1869\u20131875","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"728_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","volume":"40","author":"AM Lambeir","year":"2003","unstructured":"Lambeir AM et al (2003) Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 40(3):209\u2013294","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"2","key":"728_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00489918","volume":"89","author":"S Hartel","year":"1988","unstructured":"Hartel S et al (1988) Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry. Histochemistry 89(2):151\u2013161","journal-title":"Histochemistry"},{"issue":"3","key":"728_CR4","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.133.3.1250","volume":"133","author":"DA Fox","year":"1984","unstructured":"Fox DA et al (1984) Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. J Immunol 133(3):1250\u20131256","journal-title":"J Immunol"},{"issue":"8","key":"728_CR5","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.4049\/jimmunol.144.8.2908","volume":"144","author":"M Hegen","year":"1990","unstructured":"Hegen M et al (1990) The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 144(8):2908\u20132914","journal-title":"J Immunol"},{"issue":"1","key":"728_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2567.1997.00230.x","volume":"91","author":"T Yamabe","year":"1997","unstructured":"Yamabe T et al (1997) Induction of the 2B9 antigen\/dipeptidyl peptidase IV\/CD26 on human natural killer cells by IL-2, IL-12 or IL-15. Immunology 91(1):151\u2013158","journal-title":"Immunology"},{"issue":"3","key":"728_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00577838","volume":"7","author":"VK Hopsu-Havu","year":"1966","unstructured":"Hopsu-Havu VK, Glenner GG (1966) A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 7(3):197\u2013201","journal-title":"Histochemie"},{"issue":"18","key":"728_CR8","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1016\/S0021-9258(17)39973-8","volume":"252","author":"WP Schrader","year":"1977","unstructured":"Schrader WP, Stacy AR (1977) Purification and subunit structure of adenosine deaminase from human kidney. J Biol Chem 252(18):6409\u20136415","journal-title":"J Biol Chem"},{"issue":"4","key":"728_CR9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.177.4.1135","volume":"177","author":"ME Morrison","year":"1993","unstructured":"Morrison ME et al (1993) A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med 177(4):1135\u20131143","journal-title":"J Exp Med"},{"issue":"5120","key":"728_CR10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.8101391","volume":"261","author":"J Kameoka","year":"1993","unstructured":"Kameoka J et al (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261(5120):466\u2013469","journal-title":"Science"},{"issue":"2","key":"728_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1078\/0171-9335-00302","volume":"82","author":"E Boonacker","year":"2003","unstructured":"Boonacker E, Van Noorden CJF (2003) The multifunctional or moonlighting protein CD26\/DPPIV. Eur J Cell Biol 82(2):53\u201373","journal-title":"Eur J Cell Biol"},{"issue":"8","key":"728_CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0167-5699(99)01486-3","volume":"20","author":"I Meester De","year":"1999","unstructured":"De Meester I et al (1999) CD26, let it cut or cut it down. Immunol Today 20(8):367\u2013375","journal-title":"Immunol Today"},{"issue":"6","key":"728_CR13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","volume":"29","author":"K Ohnuma","year":"2008","unstructured":"Ohnuma K, Dang NH, Morimoto C (2008) Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol 29(6):295\u2013301","journal-title":"Trends Immunol"},{"issue":"3","key":"728_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-3083.2001.00984.x","volume":"54","author":"MD Gorrell","year":"2001","unstructured":"Gorrell MD et al (2001) CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol 54(3):249\u2013264","journal-title":"Scand J Immunol"},{"issue":"3","key":"728_CR15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1357-2725(03)00262-0","volume":"36","author":"P Busek","year":"2004","unstructured":"Busek P, Mal\u00edk R, Sedo A (2004) Dipeptidyl peptidase IV activity and\/or structure homologues (DASH) and their substrates in cancer. Int J Biochem Cell Biol 36(3):408\u2013421","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"728_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17530059.2.6.677","volume":"2","author":"A Sedo","year":"2008","unstructured":"Sedo A et al (2008) Dipeptidyl peptidase-IV and related molecules: markers of malignancy? Expert Opin Med Diagn 2(6):1\u201313","journal-title":"Expert Opin Med Diagn"},{"issue":"27","key":"728_CR17","doi-asserted-by":"crossref","first-page":"24849","DOI":"10.1074\/jbc.M212978200","volume":"278","author":"FJ Salgado","year":"2003","unstructured":"Salgado FJ et al (2003) A role for interleukin-12 in the regulation of T cell plasma membrane compartmentation. J Biol Chem 278(27):24849\u201324857","journal-title":"J Biol Chem"},{"issue":"27","key":"728_CR18","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.1073\/pnas.0501050102","volume":"102","author":"R Pacheco","year":"2005","unstructured":"Pacheco R et al (2005) CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc Natl Acad Sci USA 102(27):9583\u20139588","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"728_CR19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.mcn.2005.02.003","volume":"29","author":"X Ren","year":"2005","unstructured":"Ren X et al (2005) Transmembrane interaction mediates complex formation between peptidase homologues and Kv4 channels. Mol Cell Neurosci 29(2):320\u2013332","journal-title":"Mol Cell Neurosci"},{"issue":"9","key":"728_CR20","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/0008-5472.CAN-05-1245","volume":"66","author":"G Ghersi","year":"2006","unstructured":"Ghersi G et al (2006) The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices. Cancer Res 66(9):4652\u20134661","journal-title":"Cancer Res"},{"issue":"2\u20133","key":"728_CR21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1023055600919","volume":"22","author":"W-T Chen","year":"2003","unstructured":"Chen W-T, Kelly T (2003) Seprase complexes in cellular invasiveness. Cancer Metastasis Rev 22(2\u20133):259\u2013269","journal-title":"Cancer Metastasis Rev"},{"issue":"27","key":"728_CR22","doi-asserted-by":"crossref","first-page":"24600","DOI":"10.1074\/jbc.M303424200","volume":"278","author":"HC Cheng","year":"2003","unstructured":"Cheng HC, Abdel-Ghany M, Pauli BU (2003) A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem 278(27):24600\u201324607","journal-title":"J Biol Chem"},{"issue":"6","key":"728_CR23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-06-1746","volume":"13","author":"LR Henry","year":"2007","unstructured":"Henry LR et al (2007) Clin Cancer Res 13(6):1736\u20131741","journal-title":"Clin Cancer Res"},{"issue":"3","key":"728_CR24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1158\/1535-7163.MCT-04-0269","volume":"4","author":"JD Cheng","year":"2005","unstructured":"Cheng JD et al (2005) Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth. Mol Cancer Ther 4(3):351\u2013360","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"728_CR25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI111009","volume":"72","author":"A Morita","year":"1983","unstructured":"Morita A et al (1983) Intestinal assimilation of a proline-containing tetrapeptide. Role of a brush border membrane postproline dipeptidyl aminopeptidase IV. J Clin Invest 72(2):610\u2013616","journal-title":"J Clin Invest"},{"issue":"1 Pt 1","key":"728_CR26","first-page":"G81","volume":"265","author":"C Tiruppathi","year":"1993","unstructured":"Tiruppathi C et al (1993) Genetic evidence for role of DPP IV in intestinal hydrolysis and assimilation of prolyl peptides. Am J Physiol 265(1 Pt 1):G81\u2013G89","journal-title":"Am J Physiol"},{"issue":"12","key":"728_CR27","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1074\/jbc.M109357200","volume":"277","author":"M Alfalah","year":"2002","unstructured":"Alfalah M, Jacob R, Naim HY (2002) Intestinal dipeptidyl peptidase IV is efficiently sorted to the apical membrane through the concerted action of N- and O-glycans as well as association with lipid microdomains. J Biol Chem 277(12):10683\u201310690","journal-title":"J Biol Chem"},{"issue":"52","key":"728_CR28","doi-asserted-by":"crossref","first-page":"42636","DOI":"10.1074\/jbc.M505924200","volume":"280","author":"M Alfalah","year":"2005","unstructured":"Alfalah M et al (2005) A novel type of detergent-resistant membranes may contribute to an early protein sorting event in epithelial cells. J Biol Chem 280(52):42636\u201342643","journal-title":"J Biol Chem"},{"issue":"9","key":"728_CR29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1096\/fasebj.9.9.7601338","volume":"9","author":"G Vanhoof","year":"1995","unstructured":"Vanhoof G et al (1995) Proline motifs in peptides and their biological processing. FASEB J 9(9):736\u2013744","journal-title":"FASEB J"},{"issue":"2","key":"728_CR30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2007.10.009","volume":"29","author":"G Murphy","year":"2008","unstructured":"Murphy G, Murthy A, Khokha R (2008) Clipping, shedding and RIPping keep immunity on cue. Trends Immunol 29(2):75\u201382","journal-title":"Trends Immunol"},{"key":"728_CR31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","volume":"214","author":"R Mentlein","year":"1993","unstructured":"Mentlein R, Gallwitz B, Schmidt WE (1993) Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7\u201336)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 214:829\u2013835","journal-title":"Eur J Biochem"},{"issue":"8","key":"728_CR32","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","volume":"136","author":"TJ Kieffer","year":"1995","unstructured":"Kieffer TJ, McIntosh CH, Pederson RA (1995) Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136(8):3585\u20133596","journal-title":"Endocrinology"},{"issue":"3","key":"728_CR33","first-page":"952","volume":"80","author":"CF Deacon","year":"1995","unstructured":"Deacon CF, Johnsen AH, Holst JJ (1995) Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80(3):952\u2013957","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"728_CR34","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","volume":"140","author":"L Hansen","year":"1999","unstructured":"Hansen L et al (1999) Glucagon-like peptide-1-(7\u201336)amide is transformed to glucagon-like peptide-1-(9\u201336)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140(11):5356\u20135363","journal-title":"Endocrinology"},{"issue":"6","key":"728_CR35","doi-asserted-by":"crossref","first-page":"H2401","DOI":"10.1152\/ajpheart.00347.2005","volume":"289","author":"LA Nikolaidis","year":"2005","unstructured":"Nikolaidis LA et al (2005) Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 289(6):H2401\u2013H2408","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"728_CR36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2004.061440","volume":"54","author":"PB Jeppesen","year":"2005","unstructured":"Jeppesen PB et al (2005) Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54(9):1224\u20131231","journal-title":"Gut"},{"issue":"10","key":"728_CR37","first-page":"3575","volume":"85","author":"CF Deacon","year":"2000","unstructured":"Deacon CF et al (2000) Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab 85(10):3575\u20133581","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"728_CR38","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/diabetes.50.7.1588","volume":"50","author":"CF Deacon","year":"2001","unstructured":"Deacon CF et al (2001) Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs. Diabetes 50(7):1588\u20131597","journal-title":"Diabetes"},{"issue":"3","key":"728_CR39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-0115(00)00170-1","volume":"96","author":"JA Pospisilik","year":"2001","unstructured":"Pospisilik JA et al (2001) Metabolism of glucagon by dipeptidyl peptidase IV (CD26). Regul Pept 96(3):133\u2013141","journal-title":"Regul Pept"},{"issue":"6","key":"728_CR40","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1074\/jbc.275.6.3827","volume":"275","author":"SA Hinke","year":"2000","unstructured":"Hinke SA et al (2000) Dipeptidyl peptidase IV (DPIV\/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs. J Biol Chem 275(6):3827\u20133834","journal-title":"J Biol Chem"},{"issue":"3","key":"728_CR41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0014-5793(01)02982-9","volume":"507","author":"AM Lambeir","year":"2001","unstructured":"Lambeir AM et al (2001) Kinetic study of the processing by dipeptidyl-peptidase IV\/CD26 of neuropeptides involved in pancreatic insulin secretion. FEBS Lett 507(3):327\u2013330","journal-title":"FEBS Lett"},{"issue":"9","key":"728_CR42","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1016\/S0021-9258(20)81930-9","volume":"258","author":"JR Reeve Jr","year":"1983","unstructured":"Reeve JR Jr (1983) Amino acid sequences of three bombesin-like peptides from canine intestine extracts. J Biol Chem 258(9):5582\u20135588","journal-title":"J Biol Chem"},{"issue":"6","key":"728_CR43","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1381\/096089206777346619","volume":"16","author":"GH Ballantyne","year":"2006","unstructured":"Ballantyne GH (2006) Peptide YY(1\u201336) and peptide YY(3\u201336). Part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 16(6):795\u2013803","journal-title":"Obes Surg"},{"issue":"5","key":"728_CR44","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1381\/096089206776944959","volume":"16","author":"GH Ballantyne","year":"2006","unstructured":"Ballantyne GH (2006) Peptide YY(1-36) and peptide YY(3-36). Part I. Distribution, release and actions. Obes Surg 16(5):651\u2013658","journal-title":"Obes Surg"},{"issue":"1","key":"728_CR45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1440-1681.2007.04737.x","volume":"35","author":"EK Jackson","year":"2008","unstructured":"Jackson EK, Dubinion JH, Mi Z (2008) Effects of dipeptidyl peptidase IV inhibition on arterial blood pressure. Clin Exp Pharmacol Physiol 35(1):29\u201334","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"728_CR46","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1210\/endo.134.5.7908871","volume":"134","author":"MD Medeiros","year":"1994","unstructured":"Medeiros MD, Turner AJ (1994) Processing and metabolism of peptide-YY: pivotal roles of dipeptidylpeptidase-IV, aminopeptidase-P, and endopeptidase-24.11. Endocrinology 134(5):2088\u20132094","journal-title":"Endocrinology"},{"issue":"1","key":"728_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","volume":"85","author":"R Mentlein","year":"1999","unstructured":"Mentlein R (1999) Dipeptidyl-peptidase IV (CD26)\u2014role in the inactivation of regulatory peptides. Regul Pept 85(1):9\u201324","journal-title":"Regul Pept"},{"issue":"1","key":"728_CR48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/HYPERTENSIONAHA.107.096552","volume":"51","author":"JB Byrd","year":"2008","unstructured":"Byrd JB et al (2008) Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema. Hypertension 51(1):141\u2013147","journal-title":"Hypertension"},{"issue":"5","key":"728_CR49","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bjp.0707641","volume":"153","author":"RM Fryer","year":"2008","unstructured":"Fryer RM et al (2008) Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema. Br J Pharmacol 153(5):947\u2013955","journal-title":"Br J Pharmacol"},{"issue":"12","key":"728_CR50","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/00004872-199210120-00006","volume":"10","author":"JB Pesquero","year":"1992","unstructured":"Pesquero JB et al (1992) Bradykinin metabolism pathway in the rat pulmonary circulation. J Hypertens 10(12):1471\u20131478","journal-title":"J Hypertens"},{"issue":"4","key":"728_CR51","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0196-9781(96)00066-6","volume":"17","author":"R Mentlein","year":"1996","unstructured":"Mentlein R, Roos T (1996) Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells. Peptides 17(4):709\u2013720","journal-title":"Peptides"},{"issue":"1","key":"728_CR52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1373\/clinchem.2005.057638","volume":"52","author":"I Brandt","year":"2006","unstructured":"Brandt I et al (2006) Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin Chem 52(1):82\u201387","journal-title":"Clin Chem"},{"issue":"4","key":"728_CR53","first-page":"A18","volume":"46","author":"M Vanderheyden","year":"2008","unstructured":"Vanderheyden M (2008) Clinical importance of BNP truncation by DPPIV. Clin Chem Lab Med 46(4):A18","journal-title":"Clin Chem Lab Med"},{"issue":"17","key":"728_CR54","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.2174\/156802607782340948","volume":"7","author":"K Abe","year":"2007","unstructured":"Abe K, Tilan JU, Zukowska Z (2007) NPY and NPY receptors in vascular remodeling. Curr Top Med Chem 7(17):1704\u20131709","journal-title":"Curr Top Med Chem"},{"issue":"7","key":"728_CR55","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nm1611","volume":"13","author":"LE Kuo","year":"2007","unstructured":"Kuo LE et al (2007) Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13(7):803\u2013811","journal-title":"Nat Med"},{"issue":"5","key":"728_CR56","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1158\/0008-5472.CAN-04-2192","volume":"65","author":"J Kitlinska","year":"2005","unstructured":"Kitlinska J et al (2005) Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res 65(5):1719\u20131728","journal-title":"Cancer Res"},{"issue":"3","key":"728_CR57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.peptides.2006.11.014","volume":"28","author":"B Jarmo\u0142owska","year":"2007","unstructured":"Jarmo\u0142owska B et al (2007) Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy. Peptides 28(3):678\u2013682","journal-title":"Peptides"},{"issue":"3","key":"728_CR58","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0021-9258(19)40041-0","volume":"256","author":"C Tiruppathi","year":"1990","unstructured":"Tiruppathi C et al (1990) Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and dipeptidyl peptidase IV-negative rat strains. J Biol Chem 256(3):1476\u20131483","journal-title":"J Biol Chem"},{"issue":"2","key":"728_CR59","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbr.2005.08.003","volume":"166","author":"R Guieu","year":"2006","unstructured":"Guieu R et al (2006) CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity. Behav Brain Res 166(2):230\u2013235","journal-title":"Behav Brain Res"},{"issue":"7","key":"728_CR60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuint.2006.05.006","volume":"49","author":"Z Bagosi","year":"2006","unstructured":"Bagosi Z et al (2006) The effects of endomorphins and diprotin A on striatal dopamine release induced by electrical stimulation\u2014an in vitro superfusion study in rats. Neurochem Int 49(7):665\u2013668","journal-title":"Neurochem Int"},{"issue":"1","key":"728_CR61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0031-9384(03)00229-4","volume":"80","author":"T Karl","year":"2003","unstructured":"Karl T et al (2003) Extreme reduction of dipeptidyl peptidase IV activity in F344 rat substrains is associated with various behavioral differences. Physiol Behav 80(1):123\u2013134","journal-title":"Physiol Behav"},{"issue":"9","key":"728_CR62","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1096\/fj.01-0939fje","volume":"16","author":"E Grouzmann","year":"2002","unstructured":"Grouzmann E et al (2002) Loss of dipeptidylpeptidase IV activity in chronic rhino sinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa. FASEB J 16(9):1132\u20131134","journal-title":"FASEB J"},{"issue":"3","key":"728_CR63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.33549\/physiolres.931231","volume":"57","author":"P Busek","year":"2008","unstructured":"Busek P et al (2008) Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines. Physiol Res 57(3):443\u2013449","journal-title":"Physiol Res"},{"issue":"5","key":"728_CR64","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood.V96.5.1674","volume":"96","author":"P Proost","year":"2000","unstructured":"Proost P et al (2000) Cleavage by CD26\/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist. Blood 96(5):1674\u20131680","journal-title":"Blood"},{"issue":"7","key":"728_CR65","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/1521-4141(200107)31:7<2170::AID-IMMU2170>3.0.CO;2-D","volume":"31","author":"S Struyf","year":"2001","unstructured":"Struyf S et al (2001) Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur J Immunol 31(7):2170\u20132178","journal-title":"Eur J Immunol"},{"issue":"1","key":"728_CR66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jcb.20041","volume":"92","author":"E Guan","year":"2004","unstructured":"Guan E, Wang J, Norcross MA (2004) Amino-terminal processing of MIP-1beta\/CCL4 by CD26\/dipeptidyl-peptidase IV. J Cell Biochem 92(1):53\u201364","journal-title":"J Cell Biochem"},{"key":"728_CR67","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2741\/2800","volume":"13","author":"TB Campbell","year":"2008","unstructured":"Campbell TB, Broxmeyer HE (2008) CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation. Front Biosci 13:1795\u20131805","journal-title":"Front Biosci"},{"issue":"11","key":"728_CR68","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1084\/jem.186.11.1865","volume":"186","author":"T Oravecz","year":"1997","unstructured":"Oravecz T et al (1997) Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 186(11):1865\u20131872","journal-title":"J Exp Med"},{"issue":"3","key":"728_CR69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-3542(98)00039-4","volume":"39","author":"D Schols","year":"1998","unstructured":"Schols D et al (1998) CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity. Antiviral Res 39(3):175\u2013187","journal-title":"Antiviral Res"},{"issue":"13","key":"728_CR70","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1074\/jbc.273.13.7222","volume":"273","author":"P Proost","year":"1998","unstructured":"Proost P et al (1998) Amino-terminal truncation of chemokines by CD26\/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem 273(13):7222\u20137227","journal-title":"J Biol Chem"},{"issue":"8","key":"728_CR71","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.4049\/jimmunol.162.8.4903","volume":"162","author":"S Struyf","year":"1999","unstructured":"Struyf S et al (1999) CD26\/dipeptidyl-peptidase IV downregulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 162(8):4903\u20134909","journal-title":"J Immunol"},{"issue":"2","key":"728_CR72","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4049\/jimmunol.181.2.1120","volume":"181","author":"U Forssmann","year":"2008","unstructured":"Forssmann U et al (2008) Inhibition of CD26\/dipeptidyl peptidase IV enhances CCL11\/eotaxin-mediated recruitment of eosinophils in vivo. J Immunol 181(2):1120\u20131127","journal-title":"J Immunol"},{"issue":"7","key":"728_CR73","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1074\/jbc.274.7.3988","volume":"274","author":"P Proost","year":"1999","unstructured":"Proost P et al (1999) Truncation of macrophage-derived chemokine by CD26\/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J Biol Chem 274(7):3988\u20133993","journal-title":"J Biol Chem"},{"issue":"13","key":"728_CR74","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood.V98.13.3554","volume":"98","author":"P Proost","year":"2001","unstructured":"Proost P et al (2001) Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98(13):3554\u20133561","journal-title":"Blood"},{"issue":"6","key":"728_CR75","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1042\/BST0340997","volume":"34","author":"P Proost","year":"2006","unstructured":"Proost P et al (2006) Natural posttranslational modifications of chemokines. Biochem Soc Trans 34(6):997\u20131001","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"728_CR76","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1186\/ar1997","volume":"8","author":"P Proost","year":"2006","unstructured":"Proost P et al (2006) Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies. Arthritis Res Ther 8(4):R107","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"728_CR77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1189\/jlb.72.1.183","volume":"72","author":"A Ludwig","year":"2002","unstructured":"Ludwig A et al (2002) Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J Leukoc Biol 72(1):183\u2013191","journal-title":"J Leukoc Biol"},{"issue":"1","key":"728_CR78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2006-10-049072","volume":"110","author":"P Proost","year":"2007","unstructured":"Proost P et al (2007) Proteolytic processing of CXCL11 by CD13\/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 110(1):37\u201344","journal-title":"Blood"},{"issue":"2","key":"728_CR79","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0014-5793(98)00763-7","volume":"431","author":"T Ohtsuki","year":"1998","unstructured":"Ohtsuki T et al (1998) Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1alpha by CD26\/dipeptidyl peptidase IV. FEBS Lett 431(2):236\u2013240","journal-title":"FEBS Lett"},{"issue":"1\u20132","key":"728_CR80","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-5793(98)00830-8","volume":"432","author":"P Proost","year":"1998","unstructured":"Proost P et al (1998) Processing by CD26\/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell derived factor-1alpha. FEBS Lett 432(1\u20132):73\u201376","journal-title":"FEBS Lett"},{"issue":"11","key":"728_CR81","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1073\/pnas.95.11.6331","volume":"95","author":"T Shioda","year":"1998","unstructured":"Shioda T et al (1998) Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26\/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci USA 95(11):6331\u20136336","journal-title":"Proc Natl Acad Sci USA"},{"key":"728_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(03)81001-5","volume":"81","author":"S Struyf","year":"2003","unstructured":"Struyf S et al (2003) Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 81:1\u201344","journal-title":"Adv Immunol"},{"issue":"7","key":"728_CR83","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10585-008-9188-9","volume":"25","author":"YX Sun","year":"2008","unstructured":"Sun YX et al (2008) CD26\/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1\/CXCL12. Clin Exp Metastasis 25(7):765\u2013776","journal-title":"Clin Exp Metastasis"},{"issue":"11","key":"728_CR84","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1515\/bchm3.1990.371.2.1113","volume":"371","author":"I Nausch","year":"1990","unstructured":"Nausch I et al (1990) The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta. Biol Chem Hoppe Seyler 371(11):1113\u20131118","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"1","key":"728_CR85","first-page":"3","volume":"4","author":"T Kahne","year":"1999","unstructured":"Kahne T et al (1999) Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth. Int J Mol Med 4(1):3\u201315","journal-title":"Int J Mol Med"},{"issue":"3","key":"728_CR86","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/IAI.68.3.1176-1182.2000","volume":"68","author":"A Banbula","year":"2000","unstructured":"Banbula A et al (2000) Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV. Infect Immun 68(3):1176\u20131182","journal-title":"Infect Immun"},{"key":"728_CR87","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1196\/annals.1423.042","volume":"1110","author":"D Reinhold","year":"2007","unstructured":"Reinhold D et al (2007) Dual inhibition of dipeptidyl peptidase IV and aminopeptidase N suppresses inflammatory immune responses. Ann N Y Acad Sci 1110:402\u2013409","journal-title":"Ann N Y Acad Sci"},{"key":"728_CR88","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2741\/2849","volume":"13","author":"D Reinhold","year":"2008","unstructured":"Reinhold D et al (2008) DP IV\/CD26, APN\/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis. Front Biosci 13:2356\u20132363","journal-title":"Front Biosci"},{"issue":"6\u20137","key":"728_CR89","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.biocel.2007.12.009","volume":"40","author":"M Wolf","year":"2008","unstructured":"Wolf M, Albrecht S, M\u00e4rki C (2008) Proteolytic processing of chemokines: implications in physiological and pathological conditions. Int J Biochem Cell Biol 40(6\u20137):1185\u20131198","journal-title":"Int J Biochem Cell Biol"},{"issue":"41","key":"728_CR90","doi-asserted-by":"crossref","first-page":"43330","DOI":"10.1074\/jbc.M405001200","volume":"279","author":"WA Weihofen","year":"2004","unstructured":"Weihofen WA et al (2004) Crystal structure of CD26\/dipeptidyl-peptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface. J Biol Chem 279(41):43330\u201343335","journal-title":"J Biol Chem"},{"issue":"1","key":"728_CR91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1110\/ps.03352504","volume":"13","author":"K Aertgeerts","year":"2004","unstructured":"Aertgeerts K et al (2004) N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Protein Sci 13(1):145\u2013154","journal-title":"Protein Sci"},{"issue":"6","key":"728_CR92","first-page":"673","volume":"19","author":"M Cuchacovich","year":"2001","unstructured":"Cuchacovich M et al (2001) Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases. Clin Exp Rheumatol 19(6):673\u2013680","journal-title":"Clin Exp Rheumatol"},{"issue":"5686","key":"728_CR93","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1097071","volume":"305","author":"KW Christopherson II","year":"2004","unstructured":"Christopherson KWII et al (2004) Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305(5686):1000\u20131003","journal-title":"Science"},{"key":"728_CR94","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2741\/2850","volume":"13","author":"A Thielitz","year":"2008","unstructured":"Thielitz A et al (2008) The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases. Front Biosci 13:2364\u20132375","journal-title":"Front Biosci"},{"issue":"11","key":"728_CR95","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/cbt.6.11.4874","volume":"6","author":"K Narra","year":"2007","unstructured":"Narra K et al (2007) Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer. Cancer Biol Ther 6(11):1691\u20131699","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"728_CR96","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","volume":"132","author":"LL Baggio","year":"2007","unstructured":"Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132(6):2131\u20132157","journal-title":"Gastroenterology"},{"issue":"9548","key":"728_CR97","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","volume":"368","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368(9548):1696\u20131705","journal-title":"Lancet"},{"key":"728_CR98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.med.57.110104.115624","volume":"57","author":"LL Baggio","year":"2006","unstructured":"Baggio LL, Drucker DJ (2006) Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu Rev Med 57:265\u2013281","journal-title":"Annu Rev Med"},{"issue":"32","key":"728_CR99","doi-asserted-by":"crossref","first-page":"19215","DOI":"10.1016\/S0021-9258(19)47289-X","volume":"264","author":"WN Dinjens","year":"1989","unstructured":"Dinjens WN et al (1989) Distribution of adenosine deaminase-complexing protein in murine tissues. J Biol Chem 264(32):19215\u201319220","journal-title":"J Biol Chem"},{"issue":"9","key":"728_CR100","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diab.44.9.1126","volume":"44","author":"CF Deacon","year":"1995","unstructured":"Deacon CF et al (1995) Both subcutaneously and intravenously administered glucagon-like peptide 1 are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes 44(9):1126\u20131131","journal-title":"Diabetes"},{"issue":"10","key":"728_CR101","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2337\/diabetes.54.10.2988","volume":"54","author":"GR Lankas","year":"2005","unstructured":"Lankas GR et al (2005) Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9. Diabetes 54(10):2988\u20132994","journal-title":"Diabetes"},{"key":"728_CR102","first-page":"15","volume":"1","author":"YJ Chyan","year":"2007","unstructured":"Chyan YJ, Chuang LM (2007) Dipeptidyl peptidase IV inhibitors: an evolving treatment for type 2 diabetes from the incretin concept. Recent patents on endocrine. Metab Immune Drug Discov 1:15\u201324","journal-title":"Metab Immune Drug Discov"},{"issue":"2","key":"728_CR103","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.298.2.194","volume":"298","author":"RE Amori","year":"2007","unstructured":"Amori RE, Lau J, Pittas AG (2007) Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 298(2):194\u2013206","journal-title":"JAMA"},{"issue":"15","key":"728_CR104","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.298.15.1759-b","volume":"298","author":"E Grouzmann","year":"2007","unstructured":"Grouzmann E et al (2007) Adverse effects of incretin therapy for type 2 diabetes. JAMA 298(15):1759\u20131760, author reply 1760","journal-title":"JAMA"},{"issue":"2","key":"728_CR105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/bi00595a013","volume":"77","author":"PP Trotta","year":"1978","unstructured":"Trotta PP, Balis ME (1978) Characterization of adenosine deaminase from normal coton and colon tumors. Evidence for tumor specific variants. Biochemistry 77(2):270\u2013277","journal-title":"Biochemistry"},{"issue":"10","key":"728_CR106","first-page":"4688","volume":"44","author":"J Ten Kate","year":"1984","unstructured":"Ten Kate J et al (1984) Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas. Cancer Res 44(10):4688\u20134692","journal-title":"Cancer Res"},{"issue":"1","key":"728_CR107","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01003400","volume":"17","author":"J Ten Kate","year":"1985","unstructured":"Ten Kate J et al (1985) Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity. Histochem J 17(1):23\u201331","journal-title":"Histochem J"},{"issue":"4","key":"728_CR108","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ijc.2910370402","volume":"37","author":"J Ten Kate","year":"1986","unstructured":"Ten Kate J et al (1986) Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma. Int J Cancer 37(4):479\u2013485","journal-title":"Int J Cancer"},{"issue":"5","key":"728_CR109","first-page":"983","volume":"6","author":"J Ten Kate","year":"1986","unstructured":"Ten Kate J et al (1986) Adenosine deaminase complexing protein in cancer studies. Anticancer Res 6(5):983\u2013988","journal-title":"Anticancer Res"},{"issue":"3","key":"728_CR110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/path.1711600303","volume":"160","author":"WN Dinjens","year":"1990","unstructured":"Dinjens WN et al (1990) Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas. J Pathol 160(3):195\u2013201","journal-title":"J Pathol"},{"issue":"10","key":"728_CR111","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.4049\/jimmunol.155.10.4630","volume":"155","author":"M Mart\u00edn","year":"1995","unstructured":"Mart\u00edn M et al (1995) Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule. J Immunol 155(10):4630\u20134643","journal-title":"J Immunol"},{"issue":"6","key":"728_CR112","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1189\/jlb.70.6.920","volume":"70","author":"OJ Cordero","year":"2001","unstructured":"Cordero OJ et al (2001) Cytokines regulate membrane adenosine deaminase on human activated lymphocytes. J Leukoc Biol 70(6):920\u2013930","journal-title":"J Leukoc Biol"},{"issue":"1","key":"728_CR113","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1124\/mol.59.1.127","volume":"59","author":"C Herrera","year":"2001","unstructured":"Herrera C et al (2001) Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol 59(1):127\u2013134","journal-title":"Mol Pharmacol"},{"issue":"1","key":"728_CR114","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1096\/fj.03-0011fje","volume":"18","author":"T Hashikawa","year":"2004","unstructured":"Hashikawa T et al (2004) Regulation of adenosine receptor engagement by ecto-adenosine deaminase. FASEB J 18(1):131\u2013133","journal-title":"FASEB J"},{"issue":"2","key":"728_CR115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/bj3610203","volume":"361","author":"S Gin\u00e9s","year":"2002","unstructured":"Gin\u00e9s S et al (2002) Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Biochem J 361(2):203\u2013209","journal-title":"Biochem J"},{"issue":"3","key":"728_CR116","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1084\/jem.190.3.301","volume":"190","author":"S Iwata","year":"1999","unstructured":"Iwata S, Morimoto C (1999) CD26\/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation. J Exp Med 190(3):301\u2013306","journal-title":"J Exp Med"},{"issue":"2","key":"728_CR117","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10555-007-9054-2","volume":"26","author":"D Lukashev","year":"2007","unstructured":"Lukashev D, Ohta A, Sitkovsky M (2007) Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer Metastasis Rev 26(2):273\u2013279","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"728_CR118","first-page":"527","volume":"32","author":"DW Hoskin","year":"2008","unstructured":"Hoskin DW et al (2008) Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells. Int J Oncol 32(3):527\u2013535","journal-title":"Int J Oncol"},{"issue":"4","key":"728_CR119","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tips.2006.02.004","volume":"27","author":"N White","year":"2006","unstructured":"White N, Burnstock G (2006) P2 receptors and cancer. Trends Pharmacol Sci 27(4):211\u2013217","journal-title":"Trends Pharmacol Sci"},{"key":"728_CR120","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2741\/2785","volume":"13","author":"M Gonzalez-Gronow","year":"2008","unstructured":"Gonzalez-Gronow M et al (2008) Dipeptidyl peptidase IV (DPP IV\/CD26) is a cell-surface plasminogen receptor. Front Biosci 13:1610\u20131618","journal-title":"Front Biosci"},{"key":"728_CR121","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2741\/2787","volume":"13","author":"PA Havre","year":"2008","unstructured":"Havre PA et al (2008) The role of CD26\/dipeptidyl peptidase IV in cancer. Front Biosci 13:1634\u20131645","journal-title":"Front Biosci"},{"issue":"3","key":"728_CR122","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01625433","volume":"117","author":"A Sedo","year":"1991","unstructured":"Sedo A, Krepela E, Kasaf\u00edrek E (1991) Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma. J Cancer Res Clin Oncol 117(3):249\u2013253","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"728_CR123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2559.1993.tb01199.x","volume":"23","author":"Y Asada","year":"1993","unstructured":"Asada Y et al (1993) Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma. Histopathology 23(3):265\u2013270","journal-title":"Histopathology"},{"issue":"3","key":"728_CR124","first-page":"171","volume":"43","author":"E Krepela","year":"1996","unstructured":"Krepela E et al (1996) Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma. Neoplasma 43(3):171\u2013178","journal-title":"Neoplasma"},{"issue":"51","key":"728_CR125","doi-asserted-by":"crossref","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","volume":"274","author":"JE Park","year":"1999","unstructured":"Park JE et al (1999) Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 274(51):36505\u201336512","journal-title":"J Biol Chem"},{"issue":"13","key":"728_CR126","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/pmic.200600654","volume":"7","author":"J Davoodi","year":"2007","unstructured":"Davoodi J et al (2007) The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Proteomics 7(13):2300\u20132310","journal-title":"Proteomics"},{"issue":"6","key":"728_CR127","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1309\/HCQWPWD50XHD2DW6","volume":"129","author":"D Baumhoer","year":"2008","unstructured":"Baumhoer D et al (2008) Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples. Am J Clin Pathol 129(6):899\u2013906","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"728_CR128","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/carcin\/bgn091","volume":"29","author":"W Cheng","year":"2008","unstructured":"Cheng W et al (2008) Glypican-3-mediated oncogenesis involves the insulin-like growth factor-signaling pathway. Carcinogenesis 29(7):1319\u20131326","journal-title":"Carcinogenesis"},{"issue":"2","key":"728_CR129","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.yexmp.2006.10.010","volume":"82","author":"BD Jakubovic","year":"2007","unstructured":"Jakubovic BD, Jothy S (2007) Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma. Exp Mol Pathol 82(2):184\u2013189","journal-title":"Exp Mol Pathol"},{"issue":"9","key":"728_CR130","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbapap.2008.01.006","volume":"1784","author":"P O\u2019Brien","year":"2008","unstructured":"O\u2019Brien P, O\u2019Connor BF (2008) Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta 1784(9):1130\u20131145","journal-title":"Biochim Biophys Acta"},{"issue":"14","key":"728_CR131","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1158\/1078-0432.CCR-07-5211","volume":"14","author":"E Ostermann","year":"2008","unstructured":"Ostermann E et al (2008) Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts. Clin Cancer Res 14(14):4584\u20134592","journal-title":"Clin Cancer Res"},{"issue":"2","key":"728_CR132","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1523-1747.2003.12035.x","volume":"120","author":"MA Huber","year":"2003","unstructured":"Huber MA et al (2003) Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J Invest Dermatol 120(2):182\u2013188","journal-title":"J Invest Dermatol"},{"issue":"1\u20132","key":"728_CR133","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000151741","volume":"75","author":"MA Goscinski","year":"2008","unstructured":"Goscinski MA et al (2008) Seprase, dipeptidyl peptidase IV and Urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China. Oncology 75(1\u20132):49\u201359","journal-title":"Oncology"},{"issue":"4","key":"728_CR134","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0092-8674(00)80429-8","volume":"91","author":"Z Werb","year":"1997","unstructured":"Werb Z (1997) ECM and cell surface proteolysis: regulating cellular ecology. Cell 91(4):439\u2013442","journal-title":"Cell"},{"issue":"1","key":"728_CR135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1042\/bj2620327","volume":"262","author":"GA Piazza","year":"1989","unstructured":"Piazza GA et al (1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem J 262(1):327\u2013334","journal-title":"Biochem J"},{"issue":"12","key":"728_CR136","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","volume":"91","author":"MJ Scanlan","year":"1994","unstructured":"Scanlan MJ et al (1994) Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 91(12):5657\u20135661","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"728_CR137","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.stem.2007.11.009","volume":"1","author":"JB Sneddon","year":"2007","unstructured":"Sneddon JB, Werb Z (2007) Location, location, location: the cancer stem cell niche. Cell Stem Cell 1(6):607\u2013611","journal-title":"Cell Stem Cell"},{"issue":"1","key":"728_CR138","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1097-0320(19980215)34:1<30::AID-CYTO5>3.0.CO;2-I","volume":"34","author":"P Ruiz","year":"1998","unstructured":"Ruiz P et al (1998) CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma. Cytometry 34(1):30\u201335","journal-title":"Cytometry"},{"issue":"5","key":"728_CR139","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1365-2141.2003.04365.x","volume":"121","author":"NH Dang","year":"2003","unstructured":"Dang NH et al (2003) T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition. Br J Haematol 121(5):857\u2013865","journal-title":"Br J Haematol"},{"issue":"12","key":"728_CR140","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1182\/blood.V86.12.4617.bloodjournal86124617","volume":"86","author":"A Carbone","year":"1995","unstructured":"Carbone A et al (1995) The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkins-lymphomas leukemias. Blood 86(12):4617\u20134626","journal-title":"Blood"},{"issue":"7\u20138","key":"728_CR141","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.bjc.6690167","volume":"79","author":"B Bauvois","year":"1999","unstructured":"Bauvois B et al (1999) Constitutive expression of CD26\/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. Br J Cancer 79(7\u20138):1042\u20131048","journal-title":"Br J Cancer"},{"issue":"3","key":"728_CR142","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1440-1827.1999.00859.x","volume":"49","author":"K Hirai","year":"1999","unstructured":"Hirai K et al (1999) Dipeptidyl peptidase IV (DPP IV\/CD26) staining predicts distant metastasis of \u2018benign\u2019 thyroid tumor. Pathol Int 49(3):264\u2013265","journal-title":"Pathol Int"},{"issue":"4","key":"728_CR143","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/sj.bjc.6604194","volume":"98","author":"C Micco de","year":"2008","unstructured":"de Micco C et al (2008) Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. Br J Cancer 98(4):818\u2013823","journal-title":"Br J Cancer"},{"issue":"4","key":"728_CR144","first-page":"785","volume":"31","author":"J Stremenova","year":"2007","unstructured":"Stremenova J et al (2007) Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int J Oncol 31(4):785\u2013792","journal-title":"Int J Oncol"},{"issue":"25","key":"728_CR145","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1200\/JCO.2007.14.2331","volume":"26","author":"U Yamaguchi","year":"2008","unstructured":"Yamaguchi U et al (2008) Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 26(25):4100\u20134108","journal-title":"J Clin Oncol"},{"key":"728_CR146","doi-asserted-by":"crossref","unstructured":"Cro L et al (2009) CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. Hematol Oncol Feb 26 on-line","DOI":"10.1002\/hon.888"},{"key":"728_CR147","doi-asserted-by":"crossref","unstructured":"Carlucci F et al (2009) A 57-gene expression signature in B-cell chronic lymphocytic leukemia. Biomed Pharmacother. doi: 10.1016\/j.biopha.2009.02.001","DOI":"10.1016\/j.biopha.2009.02.001"},{"issue":"3","key":"728_CR148","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/01.ju.0000168621.84017.5c","volume":"74","author":"MJ Wilson","year":"2005","unstructured":"Wilson MJ et al (2005) Elevation of dipeptidylpeptidase IV activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker. J Urol 74(3):1124\u20131128","journal-title":"J Urol"},{"issue":"3","key":"728_CR149","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01625433","volume":"117","author":"A Sedo","year":"1991","unstructured":"Sedo A, Krepela E, Kasafirek E (1991) Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma. J Cancer Res Clin Oncol 117(3):249\u2013253","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"728_CR150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0009-8981(87)90348-2","volume":"167","author":"J Kojima","year":"1987","unstructured":"Kojima J et al (1987) Glycylproline dipeptidyl aminopeptidase and gamma-glutamyl-transferase transpeptidase in human hepatic cancer and embryonal tissues. Clin Chim Acta 167(3):285\u2013291","journal-title":"Clin Chim Acta"},{"issue":"3","key":"728_CR151","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0560.1995.tb00745.x","volume":"22","author":"MC Moehrle","year":"1995","unstructured":"Moehrle MC et al (1995) Aminopeptidase-M and dipeptidyl peptidase-IV activity in epithelial skin tumors\u2014a histochemical-study. J Cutan Pathol 22(3):241\u2013247","journal-title":"J Cutan Pathol"},{"issue":"10","key":"728_CR152","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/modpathol.3800663","volume":"19","author":"A Roesch","year":"2006","unstructured":"Roesch A et al (2006) Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi. Mod Pathol 19(10):1378\u20131385","journal-title":"Mod Pathol"},{"issue":"14","key":"728_CR153","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1158\/1078-0432.CCR-07-0110","volume":"13","author":"T Inamoto","year":"2007","unstructured":"Inamoto T et al (2007) Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors. Clin Cancer Res 13(14):4191\u20134200","journal-title":"Clin Cancer Res"},{"issue":"11 Pt1","key":"728_CR154","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1158\/1078-0432.CCR-06-0361","volume":"12","author":"T Inamoto","year":"2006","unstructured":"Inamoto T et al (2006) Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix. Clin Cancer Res 12(11 Pt1):3470\u20133477","journal-title":"Clin Cancer Res"},{"issue":"6 Suppl 2","key":"728_CR155","first-page":"17","volume":"14","author":"S Verstovsek","year":"2000","unstructured":"Verstovsek S, Cabanillas F, Dang NH (2000) CD26 in T-cell lymphomas: a potential clinical role? Oncology (Huntingt) 14(6 Suppl 2):17\u201323","journal-title":"Oncology (Huntingt)"},{"issue":"6","key":"728_CR156","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV","volume":"115","author":"D Jones","year":"2001","unstructured":"Jones D et al (2001) Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 115(6):885\u2013892","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"728_CR157","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","volume":"144","author":"MG Bernengo","year":"2001","unstructured":"Bernengo MG et al (2001) The relevance of the CD4+ CD26\u2212 subset in the identification of circulating S\u00e9zary cells. Br J Dermatol 144(1):125\u2013135","journal-title":"Br J Dermatol"},{"issue":"4","key":"728_CR158","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0145-2126(95)00159-X","volume":"20","author":"S Kondo","year":"1996","unstructured":"Kondo S et al (1996) Expression of CD26\/dipeptidyl peptidase IV in adult T cell leukemia\/lymphoma (ATLL). Leuk Res 20(4):357\u2013363","journal-title":"Leuk Res"},{"issue":"4","key":"728_CR159","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2133.1998.02171.x","volume":"138","author":"JJ Oord Van den","year":"1998","unstructured":"Van den Oord JJ (1998) Expression of CD26\/dipeptidyl-peptidase IV in benign and malignant pigment-cell lesions of the skin. Br J Dermatol 138(4):615\u2013621","journal-title":"Br J Dermatol"},{"issue":"3","key":"728_CR160","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1067\/mob.2003.169","volume":"188","author":"EE Khin","year":"2003","unstructured":"Khin EE et al (2003) Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade. Am J Obstet Gynecol 188(3):670\u2013676","journal-title":"Am J Obstet Gynecol"},{"key":"728_CR161","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/0-306-47920-6_29","volume":"524","author":"H Kajiyama","year":"2003","unstructured":"Kajiyama H et al (2003) Expression of CD26\/dipeptidyl peptidase IV in endometrial adenocarcinoma and its negative correlation with tumor grade. Adv Exp Med Biol 524:245\u2013248","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"728_CR162","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1097-0045(19971201)33:4<225::AID-PROS1>3.0.CO;2-G","volume":"33","author":"T Bogenrieder","year":"1997","unstructured":"Bogenrieder T et al (1997) Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate 33(4):225\u2013232","journal-title":"Prostate"},{"issue":"1","key":"728_CR163","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.167.1.197","volume":"167","author":"AN Houghton","year":"1988","unstructured":"Houghton AN et al (1988) Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J Exp Med 167(1):197\u2013212","journal-title":"J Exp Med"},{"issue":"4","key":"728_CR164","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.177.4.1135","volume":"177","author":"ME Morrison","year":"1993","unstructured":"Morrison ME et al (1993) A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J Exp Med 177(4):1135\u20131143","journal-title":"J Exp Med"},{"issue":"11","key":"728_CR165","first-page":"2315","volume":"7","author":"AP Albino","year":"1992","unstructured":"Albino AP et al (1992) Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype. Oncogene 7(11):2315\u20132321","journal-title":"Oncogene"},{"issue":"3","key":"728_CR166","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.190.3.311","volume":"190","author":"UV Wesley","year":"1999","unstructured":"Wesley UV et al (1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 190(3):311\u2013322","journal-title":"J Exp Med"},{"issue":"6","key":"728_CR167","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ijc.20091","volume":"109","author":"UV Wesley","year":"2004","unstructured":"Wesley UV et al (2004) Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Cancer 109(6):855\u2013866","journal-title":"Int J Cancer"},{"issue":"4","key":"728_CR168","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/0008-5472.CAN-04-1852","volume":"65","author":"UV Wesley","year":"2005","unstructured":"Wesley UV, McGroarty M, Homoyouni A (2005) Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res 65(4):1325\u20131334","journal-title":"Cancer Res"},{"issue":"10","key":"728_CR169","first-page":"2753","volume":"62","author":"H Kajiyama","year":"2002","unstructured":"Kajiyama H et al (2002) Prolonged survival and decreased invasive activity attributable to dipeptidyl peptidase IV overexpression in ovarian carcinoma. Cancer Res 62(10):2753\u20132757","journal-title":"Cancer Res"},{"issue":"1","key":"728_CR170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbapap.2004.09.028","volume":"1751","author":"F Kikkawa","year":"2005","unstructured":"Kikkawa F et al (2005) Dipeptidyl peptidase IV in tumor progression. Biochim Biophys Acta 1751(1):45\u201351","journal-title":"Biochim Biophys Acta"},{"key":"728_CR171","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.2741\/2846","volume":"13","author":"P Busek","year":"2008","unstructured":"Busek P, Stremenova J, Sedo A (2008) Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors-good or evil? Front Biosci 13:2319\u20132326","journal-title":"Front Biosci"},{"issue":"7","key":"728_CR172","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.4049\/jimmunol.178.7.4632","volume":"178","author":"V Preller","year":"2007","unstructured":"Preller V et al (2007) TGF-beta1-mediated control of central nervous system inflammation and autoimmunity through the inhibitory receptor CD26. J Immunol 178(7):4632\u20134640","journal-title":"J Immunol"},{"issue":"6917","key":"728_CR173","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860\u2013867","journal-title":"Nature"},{"key":"728_CR174","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","volume":"25","author":"GA Rabinovich","year":"2007","unstructured":"Rabinovich GA, Gabrilovich D, Sotomayor EM (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25:267\u2013296","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"728_CR175","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4049\/jimmunol.166.3.2041","volume":"166","author":"A Steinbrecher","year":"2001","unstructured":"Steinbrecher A et al (2001) Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo. J Immunol 166(3):2041\u20132048","journal-title":"J Immunol"},{"issue":"9","key":"728_CR176","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00262-003-0392-9","volume":"52","author":"K Shingu","year":"2003","unstructured":"Shingu K et al (2003) CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26. Cancer Immunol Immunother 52(9):546\u2013554","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"728_CR177","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF02140813","volume":"24","author":"I Nagatsu","year":"1968","unstructured":"Nagatsu I, Nagatsu T, Yamamoto T (1968) Hydrolysis of amino acid beta-naphthylamides by aminopeptidases in human parotid salva and human serum. Experientia 24(4):347\u2013348","journal-title":"Experientia"},{"issue":"10","key":"728_CR178","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/aid.1998.14.851","volume":"14","author":"RE Smith","year":"1998","unstructured":"Smith RE et al (1998) The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subvertid adhesion molecule for HIV peptide binding. AIDS Res Hum Retroviruses 14(10):851\u2013868","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"23","key":"728_CR179","doi-asserted-by":"crossref","first-page":"16924","DOI":"10.1074\/jbc.M701610200","volume":"282","author":"G Blanc","year":"2007","unstructured":"Blanc G et al (2007) Insights into how CUB domains can exert specific functions while sharing a common fold: conserved and specific features of the CUB1 domain contribute to the molecular basis of procollagen C-proteinase enhancer-1 activity. J Biol Chem 282(23):16924\u201316933","journal-title":"J Biol Chem"},{"issue":"5","key":"728_CR180","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1515\/BC.2007.054","volume":"388","author":"C Wermter","year":"2007","unstructured":"Wermter C et al (2007) The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains. Biol Chem 388(5):513\u2013521","journal-title":"Biol Chem"},{"issue":"6723","key":"728_CR181","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/18217","volume":"398","author":"TM Gunn","year":"1999","unstructured":"Gunn TM et al (1999) The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 398(6723):152\u2013156","journal-title":"Nature"},{"issue":"23","key":"728_CR182","doi-asserted-by":"crossref","first-page":"14107","DOI":"10.1074\/jbc.270.23.14107","volume":"270","author":"JS Duke-Cohan","year":"1995","unstructured":"Duke-Cohan JS et al (1995) A novel form of dipeptidylpeptidase IV found in human serum. Isolation, characterization, and comparison with T lymphocyte membrane dipeptidylpeptidase IV (CD26). J Biol Chem 270(23):14107\u201314114","journal-title":"J Biol Chem"},{"issue":"5","key":"728_CR183","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.4049\/jimmunol.156.5.1714","volume":"156","author":"JS Duke-Cohan","year":"1996","unstructured":"Duke-Cohan JS et al (1996) Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells. J Immunol 156(5):1714\u20131721","journal-title":"J Immunol"},{"issue":"2","key":"728_CR184","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/BC.2007.017","volume":"388","author":"D Friedrich","year":"2007","unstructured":"Friedrich D et al (2007) Does human attractin have DP4 activity? Biol Chem 388(2):155\u2013162","journal-title":"Biol Chem"},{"issue":"11","key":"728_CR185","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.110139897","volume":"97","author":"W Tang","year":"2000","unstructured":"Tang W et al (2000) Secreted and membrane attractin result from alternative splicing of the human ATRN gene. Proc Natl Acad Sci USA 97(11):6025\u20136030","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"728_CR186","doi-asserted-by":"crossref","first-page":"11964","DOI":"10.1016\/S0021-9258(19)86411-6","volume":"254","author":"WP Schrader","year":"1979","unstructured":"Schrader WP, Woodward FJ, Pollara B (1979) Purification of an adenosine deaminase complexing protein from human plasma. J Biol Chem 254(23):11964\u201311968","journal-title":"J Biol Chem"},{"issue":"2","key":"728_CR187","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/oxfordjournals.jbchem.a022130","volume":"124","author":"S Iwaki-Egawa","year":"1998","unstructured":"Iwaki-Egawa S et al (1998) Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. J Biochem (Tokyo) 124(2):428\u2013433","journal-title":"J Biochem (Tokyo)"},{"issue":"17","key":"728_CR188","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1046\/j.1432-1327.2000.01634.x","volume":"267","author":"C Durinx","year":"2000","unstructured":"Durinx C et al (2000) Molecular characterization of dipeptidyl peptidase activity in serum. Soluble CD26\/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur J Biochem 267(17):5608\u20135613","journal-title":"Eur J Biochem"},{"issue":"4","key":"728_CR189","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/mgme.1998.2676","volume":"63","author":"Y Watanabe","year":"1998","unstructured":"Watanabe Y et al (1998) Aminopeptidase N in sera of healthy subjects is a different N-terminal processed derivative from the one obtained from maternal serum. Mol Genet Metab 63(4):289\u2013294","journal-title":"Mol Genet Metab"},{"issue":"7","key":"728_CR190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1515\/bchm3.1995.376.7.397","volume":"376","author":"Y Watanabe","year":"1995","unstructured":"Watanabe Y et al (1995) Identification of an alanine aminopeptidase in human maternal serum as a membrane-bound aminopeptidase N. Biol Chem Hoppe Seyler 376(7):397\u2013400","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"2","key":"728_CR191","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/bj3210265","volume":"321","author":"NM Hooper","year":"1997","unstructured":"Hooper NM, Karran EH, Turner AJ (1997) Membrane protein secretases. Biochem J 321(2):265\u2013279","journal-title":"Biochem J"},{"issue":"2","key":"728_CR192","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.onc.1203292","volume":"19","author":"B Bauvois","year":"2000","unstructured":"Bauvois B et al (2000) Regulation of CD26\/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene 19(2):265\u2013272","journal-title":"Oncogene"},{"issue":"2","key":"728_CR193","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1369\/jhc.7A7319.2007","volume":"56","author":"J Schade","year":"2008","unstructured":"Schade J et al (2008) Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8\/9, and DP10 in allergic responses of the lung in rats. J Histochem Cytochem 56(2):147\u2013155","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"728_CR194","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/bj2160037","volume":"216","author":"EM Danielsen","year":"1983","unstructured":"Danielsen EM, Cowell GM, Poulsen SS (1983) Biosynthesis of intestinal microvillar proteins. Role of the Golgi complex and microtubules. Biochem J 216(1):37\u201342","journal-title":"Biochem J"},{"issue":"19","key":"728_CR195","doi-asserted-by":"crossref","first-page":"11376","DOI":"10.1074\/jbc.271.19.11376","volume":"271","author":"J Arribas","year":"1996","unstructured":"Arribas J et al (1996) Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem 271(19):11376\u201311382","journal-title":"J Biol Chem"},{"issue":"6","key":"728_CR196","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.molcel.2007.12.003","volume":"28","author":"MK Lemberg","year":"2007","unstructured":"Lemberg MK, Freeman M (2007) Cutting proteins within lipid bilayers: rhomboid structure and mechanism. Mol Cell 28(6):930\u2013940","journal-title":"Mol Cell"},{"issue":"4","key":"728_CR197","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/002215549904700407","volume":"47","author":"G Grondin","year":"1999","unstructured":"Grondin G, Hooper NM, LeBel D (1999) Specific localization of membrane dipeptidase and dipeptidyl peptidase IV in secretion granules of two different pancreatic islet cells. J Histochem Cytochem 47(4):489\u2013498","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"728_CR198","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/41.1.8093256","volume":"41","author":"MD Poulsen","year":"1993","unstructured":"Poulsen MD et al (1993) Dipeptidyl peptidase IV is sorted to the secretory granules in pancreatic islet A-cells. J Histochem Cytochem 41(1):81\u201388","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"728_CR199","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/bj1790379","volume":"179","author":"DC Macnair","year":"1979","unstructured":"Macnair DC, Kenny AJ (1979) Proteins of the kidney microvillar membrane. The amphipathic form of dipeptidyl peptidase IV. Biochem J 179(2):379\u2013395","journal-title":"Biochem J"},{"issue":"3","key":"728_CR200","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/bj3110835","volume":"311","author":"SK B\u00f6hm","year":"1995","unstructured":"B\u00f6hm SK et al (1995) Human dipeptidyl peptidase IV gene promoter: tissue-specific regulation from a TATA-less GC-rich sequence characteristic of a housekeeping gene promoter. Biochem J 311(3):835\u2013843","journal-title":"Biochem J"},{"issue":"22","key":"728_CR201","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1073\/pnas.96.22.12691","volume":"96","author":"TK Teague","year":"1999","unstructured":"Teague TK et al (1999) Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc Natl Acad Sci USA 96(22):12691\u201312696","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"728_CR202","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/75671","volume":"25","author":"L Rogge","year":"2000","unstructured":"Rogge L et al (2000) Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet 25(1):96\u2013101","journal-title":"Nat Genet"},{"issue":"4","key":"728_CR203","first-page":"60","volume":"84","author":"T Mattern","year":"1995","unstructured":"Mattern T et al (1995) Antibody-induced modulation of CD26 surface expression. Immunology 84(4):60\u2013595","journal-title":"Immunology"},{"issue":"7","key":"728_CR204","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1006\/cyto.1999.0643","volume":"12","author":"FJ Salgado","year":"2000","unstructured":"Salgado FJ et al (2000) Mechanisms of CD26\/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes. Cytokine 12(7):1136\u20131141","journal-title":"Cytokine"},{"issue":"3","key":"728_CR205","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1462-5822.2006.00827.x","volume":"9","author":"I Beau","year":"2007","unstructured":"Beau I, Berger A, Servin AL (2007) Rotavirus impairs the biosynthesis of brush-border-associated dipeptidyl peptidase IV in human enterocyte-like Caco-2\/TC7 cells. Cell Microbiol 9(3):779\u2013789","journal-title":"Cell Microbiol"},{"issue":"1","key":"728_CR206","first-page":"35","volume":"43","author":"T Hama","year":"1982","unstructured":"Hama T et al (1982) Purification of dipeptidyl-aminopeptidase IV from human kidney by anti dipeptidyl-aminopeptidase IV affinity chromatography. Mol Cell Biochem 43(1):35\u201342","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"728_CR207","first-page":"486","volume":"32","author":"E Krepela","year":"1983","unstructured":"Krepela E et al (1983) Demonstration of two molecular forms of dipeptidyl peptidase IV in normal human serum. Physiol Bohemoslov 32(6):486\u2013496","journal-title":"Physiol Bohemoslov"},{"issue":"8","key":"728_CR208","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Th\u00e9ry","year":"2002","unstructured":"Th\u00e9ry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2(8):569\u2013579","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"728_CR209","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1582-4934.2006.tb00406.x","volume":"10","author":"G Mignot","year":"2006","unstructured":"Mignot G et al (2006) Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med 10(2):376\u2013388","journal-title":"J Cell Mol Med"},{"issue":"6","key":"728_CR210","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1600-0854.2008.00734.x","volume":"9","author":"JS Schorey","year":"2008","unstructured":"Schorey JS, Bhatnagar S (2008) Exosome function: from tumor immunology to pathogen biology. Traffic 9(6):871\u2013881","journal-title":"Traffic"},{"issue":"6","key":"728_CR211","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1095\/biolreprod.104.036426","volume":"72","author":"JL Gatti","year":"2005","unstructured":"Gatti JL et al (2005) Identification, proteomic profiling, and origin of ram epididymal fluid exosome-like vesicles. Biol Reprod 72(6):1452\u20131465","journal-title":"Biol Reprod"},{"issue":"1","key":"728_CR212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bcmd.2005.04.001","volume":"35","author":"J Mallegol","year":"2005","unstructured":"Mallegol J, van Niel G, Heyman M (2005) Phenotypic and functional characterization of intestinal epithelial exosomes. Blood Cells Mol Dis 35(1):11\u201316","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"728_CR213","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1248\/bpb.31.1059","volume":"31","author":"Y Ogawa","year":"2008","unstructured":"Ogawa Y et al (2008) Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull 31(6):1059\u20131062","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"728_CR214","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9440(10)62266-3","volume":"166","author":"N Busso","year":"2005","unstructured":"Busso N et al (2005) Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166(2):433\u2013442","journal-title":"Am J Pathol"},{"issue":"3","key":"728_CR215","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","volume":"107","author":"MG Narducci","year":"2006","unstructured":"Narducci MG et al (2006) Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV. Blood 107(3):1108\u20131115","journal-title":"Blood"},{"issue":"4\u20135","key":"728_CR216","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0171-2985(11)80109-9","volume":"194","author":"S Iwaki-Egawa","year":"1995","unstructured":"Iwaki-Egawa S, Watanabe Y, Fujimoto Y (1995) Is CD26\/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain? Immunobiology 194(4\u20135):429\u2013442","journal-title":"Immunobiology"},{"issue":"12","key":"728_CR217","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1073\/pnas.120069197","volume":"97","author":"D Marguet","year":"2000","unstructured":"Marguet D et al (2000) Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci USA 97(12):6874\u20136879","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"728_CR218","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/eji.200323469","volume":"33","author":"S Yan","year":"2003","unstructured":"Yan S et al (2003) Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen. Eur J Immunol 33(6):1519\u20131527","journal-title":"Eur J Immunol"},{"issue":"1","key":"728_CR219","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0003-2697(85)90011-9","volume":"147","author":"T Nagatsu","year":"1985","unstructured":"Nagatsu T, Sakai T, Kojima K (1985) A sensitive and specific assay for dipeptidyl-aminopeptidase II in serum and tissues by liquid chromatography-fluorometry. Anal Biochem 147(1):80\u201385","journal-title":"Anal Biochem"},{"issue":"1","key":"728_CR220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0885-4505(87)90007-7","volume":"37","author":"K Kojima","year":"1987","unstructured":"Kojima K, Mihara R, Sakai T (1987) Serum activities of dipeptidyl-aminopeptidase II and dipeptidyl-aminopeptidase IV in tumor-bearing animals and in cancer patients. Biochem Med Metab Biol 37(1):35\u201341","journal-title":"Biochem Med Metab Biol"},{"issue":"1\u20132","key":"728_CR221","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2007.01.024","volume":"380","author":"MB Maes","year":"2007","unstructured":"Maes MB, Scharp\u00e9 S, De Meester I (2007) Dipeptidyl peptidase II (DPPII), a review. Clin Chim Acta 380(1\u20132):31\u201349","journal-title":"Clin Chim Acta"},{"issue":"4","key":"728_CR222","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1367-5931(03)00084-X","volume":"7","author":"JS Rosenblum","year":"2003","unstructured":"Rosenblum JS, Kozarich JW (2003) Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr Opin Chem Biol 7(4):496\u2013504","journal-title":"Curr Opin Chem Biol"},{"issue":"2","key":"728_CR223","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/BJ20041156","volume":"386","author":"MB Maes","year":"2005","unstructured":"Maes MB et al (2005) Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)\/dipeptidyl peptidase 7 (DPP7). Biochem J 386(2):315\u2013324","journal-title":"Biochem J"},{"issue":"2","key":"728_CR224","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/oxfordjournals.jbchem.a002855","volume":"129","author":"H Araki","year":"2001","unstructured":"Araki H et al (2001) Purification, molecular cloning, and immunohistochemical localization of dipeptidyl peptidase II from the rat kidney and its identity with quiescent cell proline dipeptidase. J Biochem 129(2):279\u2013288","journal-title":"J Biochem"},{"issue":"48","key":"728_CR225","doi-asserted-by":"crossref","first-page":"34053","DOI":"10.1074\/jbc.274.48.34053","volume":"274","author":"R Underwood","year":"1999","unstructured":"Underwood R et al (1999) Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J Biol Chem 274(48):34053\u201334058","journal-title":"J Biol Chem"},{"issue":"10","key":"728_CR226","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.4049\/jimmunol.165.10.5695","volume":"165","author":"M Chiravuri","year":"2000","unstructured":"Chiravuri M et al (2000) Vesicular localization and characterization of a novel post-proline-cleaving aminodipeptidase, quiescent cell proline dipeptidase. J Immunol 165(10):5695\u20135702","journal-title":"J Immunol"},{"issue":"35","key":"728_CR227","doi-asserted-by":"crossref","first-page":"26994","DOI":"10.1016\/S0021-9258(19)61470-5","volume":"275","author":"M Chiravuri","year":"2000","unstructured":"Chiravuri M et al (2000) Homodimerization via a leucine zipper motif is required for enzymatic activity of quiescent cell proline dipeptidase. J Biol Chem 275(35):26994\u201326999","journal-title":"J Biol Chem"},{"issue":"4","key":"728_CR228","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1023\/A:1009675223443","volume":"5","author":"M Chiravuri","year":"2000","unstructured":"Chiravuri M, Huber BT (2000) Aminodipeptidase inhibitor-induced cell death in quiescent lymphocytes: a review. Apoptosis 5(4):319\u2013322","journal-title":"Apoptosis"},{"issue":"1","key":"728_CR229","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bcp.2006.04.009","volume":"72","author":"MB Maes","year":"2006","unstructured":"Maes MB et al (2006) Dipeptidyl peptidase II and leukocyte cell death. Biochem Pharmacol 72(1):70\u201379","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"728_CR230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/bj2360215","volume":"236","author":"G Struckhoff","year":"1986","unstructured":"Struckhoff G, Heymann E (1986) Rat peritoneal mast cells release dipeptidyl peptidase II. Biochem J 236(1):215\u2013219","journal-title":"Biochem J"},{"issue":"5","key":"728_CR231","first-page":"581","volume":"34","author":"P Klener","year":"1987","unstructured":"Klener P et al (1987) Possible prognostic significance of the assessment of dipeptidylpeptidase II in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia. Neoplasma 34(5):581\u2013586","journal-title":"Neoplasma"},{"issue":"4","key":"728_CR232","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2141.2004.05346.x","volume":"128","author":"AV Danilov","year":"2005","unstructured":"Danilov AV et al (2005) Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor. Br J Haematol 128(4):472\u2013481","journal-title":"Br J Haematol"},{"issue":"6","key":"728_CR233","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/1097-0142(19890915)64:6<1274::AID-CNCR2820640618>3.0.CO;2-2","volume":"64","author":"M Urade","year":"1989","unstructured":"Urade M et al (1989) Serum dipeptidyl peptidase activities as a possible marker of oral cancer. Cancer 64(6):1274\u20131280","journal-title":"Cancer"},{"issue":"7","key":"728_CR234","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0003-9969(86)90028-2","volume":"31","author":"M Mogi","year":"1986","unstructured":"Mogi M et al (1986) Sandwich enzyme-immunoassay for dipeptidyl aminopeptidase IV in the serum of people with oral cancer. Arch Oral Biol 31(7):505\u2013507","journal-title":"Arch Oral Biol"},{"issue":"10","key":"728_CR235","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2003-12-4240","volume":"103","author":"KN Lee","year":"2004","unstructured":"Lee KN et al (2004) A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion. Blood 103(10):3783\u20133788","journal-title":"Blood"},{"issue":"4","key":"728_CR236","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2005-08-3452","volume":"107","author":"KN Lee","year":"2006","unstructured":"Lee KN et al (2006) Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood 107(4):1397\u20131404","journal-title":"Blood"},{"issue":"12","key":"728_CR237","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1182\/blood-2007-01-065185","volume":"109","author":"VJ Christiansen","year":"2007","unstructured":"Christiansen VJ et al (2007) The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity. Blood 109(12):5286\u20135292","journal-title":"Blood"},{"issue":"11","key":"728_CR238","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.biocel.2004.05.006","volume":"36","author":"PJ Collins","year":"2004","unstructured":"Collins PJ et al (2004) Purification, identification and characterisation of seprase from bovine serum. Int J Biochem Cell Biol 36(11):2320\u20132333","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"728_CR239","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-0037-1613388","volume":"89","author":"RT Aimes","year":"2003","unstructured":"Aimes RT et al (2003) Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thromb Haemost 89(3):561\u2013572","journal-title":"Thromb Haemost"},{"issue":"20","key":"728_CR240","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1158\/0008-5472.CAN-06-1499","volume":"66","author":"D Chen","year":"2006","unstructured":"Chen D et al (2006) Activation of EDTA-resistant gelatinases in malignant human tumors. Cancer Res 66(20):9977\u20139985","journal-title":"Cancer Res"},{"issue":"9","key":"728_CR241","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1054\/bjoc.2000.1410","volume":"83","author":"OJ Cordero","year":"2000","unstructured":"Cordero OJ et al (2000) Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer 83(9):1139\u20131146","journal-title":"Br J Cancer"},{"issue":"6","key":"728_CR242","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1155\/2004\/834309","volume":"19","author":"D Ayude","year":"2004","unstructured":"Ayude D et al (2004) Clinical interest of the combined use of serum CD26 and alpha-l-fucosidase in the early detection diagnosis of colorectal cancer. Dis Markers 19(6):267\u2013272","journal-title":"Dis Markers"},{"issue":"4","key":"728_CR243","first-page":"A23","volume":"46","author":"OJ Cordero","year":"2008","unstructured":"Cordero OJ et al (2008) Validation of serum CD26 as a screening marker for colorectal cancer. Clin Chem Lab Med 46(4):A23","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"728_CR244","first-page":"2333","volume":"28","author":"OJ Cordero","year":"2008","unstructured":"Cordero OJ et al (2008) How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer. Anticancer Res 28(4):2333\u20132341","journal-title":"Anticancer Res"},{"issue":"5","key":"728_CR245","first-page":"307","volume":"49","author":"J Haba-Rodr\u00edguez de la","year":"2002","unstructured":"de la Haba-Rodr\u00edguez J et al (2002) Soluble dipeptidyl peptidase IV (CD-26) in serum of patients with colorectal carcinoma. Neoplasma 49(5):307\u2013311","journal-title":"Neoplasma"},{"issue":"2","key":"728_CR246","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s002960100134","volume":"21","author":"OJ Cordero","year":"2001","unstructured":"Cordero OJ et al (2001) Interleukin 12, interleukin 15, soluble CD26 and adenosine deaminase levels in the sera of rheumatoid arthritis patients. Rheumatol Int 21(2):69\u201374","journal-title":"Rheumatol Int"},{"issue":"4","key":"728_CR247","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3083.2007.01966.x","volume":"66","author":"T Ellingsen","year":"2007","unstructured":"Ellingsen T et al (2007) In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes. Scand J Immunol 66(4):451\u2013457","journal-title":"Scand J Immunol"},{"issue":"6","key":"728_CR248","first-page":"1253","volume":"9","author":"M Cuchacovich","year":"2002","unstructured":"Cuchacovich M et al (2002) Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients. Clin Diagn Lab Immunol 9(6):1253\u20131259","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9","key":"728_CR249","first-page":"1858","volume":"29","author":"H Kobayashi","year":"2002","unstructured":"Kobayashi H et al (2002) Reduction of serum soluble CD26\/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. J Rheumatol 29(9):1858\u20131866","journal-title":"J Rheumatol"},{"issue":"1","key":"728_CR250","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdermsci.2008.05.004","volume":"52","author":"Z Tamaki","year":"2008","unstructured":"Tamaki Z et al (2008) Serum levels of soluble CD26 in patients with scleroderma. J Dermatol Sci 52(1):67\u201369","journal-title":"J Dermatol Sci"},{"issue":"4","key":"728_CR251","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10875-007-9093-z","volume":"27","author":"SW Lun","year":"2007","unstructured":"Lun SW et al (2007) Increased expression of plasma and CD4+ T lymphocyte costimulatory molecule CD26 in adult patients with allergic asthma. J Clin Immunol 27(4):430\u2013437","journal-title":"J Clin Immunol"},{"issue":"2","key":"728_CR252","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2249.2000.01286.x","volume":"121","author":"N Katoh","year":"2000","unstructured":"Katoh N et al (2000) Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Clin Exp Immunol 121(2):187\u2013192","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"728_CR253","first-page":"457","volume":"18","author":"U Sch\u00f6nermarck","year":"2000","unstructured":"Sch\u00f6nermarck U et al (2000) Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol 18(4):457\u2013463","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"728_CR254","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/clim.1999.4711","volume":"91","author":"O Hosono","year":"1999","unstructured":"Hosono O et al (1999) Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals. Clin Immunol 91(3):283\u2013295","journal-title":"Clin Immunol"},{"issue":"12","key":"728_CR255","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/j.1440-1746.2006.04677.x","volume":"21","author":"SS Yang","year":"2006","unstructured":"Yang SS et al (2006) Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C. J Gastroenterol Hepatol 21(12):1789\u20131793","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"728_CR256","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.2007.05183.x","volume":"23","author":"M Itou","year":"2008","unstructured":"Itou M et al (2008) Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance. J Gastroenterol Hepatol 23(2):244\u2013251","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"728_CR257","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2249.2006.03105.x","volume":"145","author":"S Ajdary","year":"2006","unstructured":"Ajdary S et al (2006) Soluble CD26\/CD30 levels in visceral leishmaniasis: markers of disease activity. Clin Exp Immunol 145(1):44\u201347","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"728_CR258","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2006.12.005","volume":"55","author":"S Ajdary","year":"2007","unstructured":"Ajdary S et al (2007) Soluble CD26 and CD30 levels in patients with anthroponotic cutaneous leishmaniasis. J Infect 55(1):75\u201378","journal-title":"J Infect"},{"issue":"2","key":"728_CR259","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1515\/CCLM.2001.026","volume":"39","author":"C Durinx","year":"2001","unstructured":"Durinx C et al (2001) Reference values for plasma dipeptidylpeptidase IV activity and their association with other laboratory parameters. Clin Chem Lab Med 39(2):155\u2013159","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"728_CR260","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/clinchem\/34.11.2299","volume":"34","author":"S Scharp\u00e9","year":"1988","unstructured":"Scharp\u00e9 S et al (1988) Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine. Clin Chem 34(11):2299\u20132301","journal-title":"Clin Chem"},{"issue":"1","key":"728_CR261","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0009-8981(75)90273-9","volume":"62","author":"M Hino","year":"1975","unstructured":"Hino M et al (1975) Glycylprolyl beta-naphthylamidase activity in human serum. Clin Chim Acta 62(1):5\u201311","journal-title":"Clin Chim Acta"},{"issue":"2","key":"728_CR262","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0009-8981(77)90220-0","volume":"74","author":"H Fuyamada","year":"1977","unstructured":"Fuyamada H et al (1977) Serum glycylproline p-nitroanilidase activity in human hypertension. Clin Chim Acta 74(2):177\u2013181","journal-title":"Clin Chim Acta"},{"issue":"2","key":"728_CR263","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0009-8981(77)90014-6","volume":"81","author":"K Fujita","year":"1977","unstructured":"Fujita K et al (1977) Serum glycylproline p-nitroanilidase activity in blood cancers. Clin Chim Acta 81(2):215\u2013217","journal-title":"Clin Chim Acta"},{"issue":"2","key":"728_CR264","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0009-8981(79)90086-X","volume":"93","author":"J Kojima","year":"1979","unstructured":"Kojima J et al (1979) Serum glycylproline dipeptidyl aminopeptidase activity in human hepatic cancer. Clin Chim Acta 93(2):181\u2013187","journal-title":"Clin Chim Acta"},{"issue":"3","key":"728_CR265","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-2944(81)90085-5","volume":"25","author":"Y Yoshii","year":"1981","unstructured":"Yoshii Y et al (1981) Changes in serum dipeptidyl-aminopeptidase IV (glycylprolyl dipeptidyl-aminopeptidase) activity of patients with gastric carcinoma after surgical excision and the enzyme activity in the carcinoma tissue. Biochem Med 25(3):276\u2013282","journal-title":"Biochem Med"},{"issue":"1","key":"728_CR266","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0885-4505(87)90007-7","volume":"37","author":"K Kojima","year":"1987","unstructured":"Kojima K et al (1987) Serum activities of dipeptidyl-aminopeptidase II and dipeptidyl-aminopeptidase IV in tumor-bearing animals and in cancer patients. Biochem Med Metab Biol 37(1):35\u201341","journal-title":"Biochem Med Metab Biol"},{"issue":"4","key":"728_CR267","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0300-9785(82)80075-6","volume":"11","author":"K Fukasawa","year":"1982","unstructured":"Fukasawa K et al (1982) Serum dipeptidyl peptidase (DPP) IV activities in oral cancer patients. Int J Oral Surg 11(4):246\u2013250","journal-title":"Int J Oral Surg"},{"issue":"6","key":"728_CR268","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/1097-0142(19890915)64:6<1274::AID-CNCR2820640618>3.0.CO;2-2","volume":"64","author":"M Urade","year":"1989","unstructured":"Urade M et al (1989) Serum dipeptidyl peptidase activities as a possible marker of oral cancer. Cancer 64(6):1274\u20131280","journal-title":"Cancer"},{"issue":"8","key":"728_CR269","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/clinchem\/33.8.1463","volume":"33","author":"M Hagihara","year":"1987","unstructured":"Hagihara M, Ohhashi M, Nagatsu T (1987) Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis. Clin Chem 33(8):1463\u20131465","journal-title":"Clin Chem"},{"issue":"12","key":"728_CR270","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/clinchem\/34.12.2499","volume":"34","author":"H Gotoh","year":"1988","unstructured":"Gotoh H et al (1988) Activity of dipeptidyl peptidase IV and post-proline cleaving enzyme in sera from osteoporotic patients. Clin Chem 34(12):2499\u20132501","journal-title":"Clin Chem"},{"issue":"4","key":"728_CR271","first-page":"381","volume":"10","author":"M Stanc\u00edkov\u00e1","year":"1992","unstructured":"Stanc\u00edkov\u00e1 M et al (1992) Dipeptidyl peptidase IV in patients with systemic lupus erythematosus. Clin Exp Rheumatol 10(4):381\u2013385","journal-title":"Clin Exp Rheumatol"},{"issue":"1\u20132","key":"728_CR272","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-8981(02)00042-6","volume":"321","author":"A Bergmann","year":"2002","unstructured":"Bergmann A, Bohuon C (2002) Decrease of serum dipeptidylpeptidase activity in severe sepsis patients: relationship to procalcitonin. Clin Chim Acta 321(1\u20132):123\u2013126","journal-title":"Clin Chim Acta"},{"issue":"1","key":"728_CR273","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-2143(99)90054-9","volume":"134","author":"F Perner","year":"1999","unstructured":"Perner F et al (1999) Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence. J Lab Clin Med 134(1):56\u201367","journal-title":"J Lab Clin Med"},{"issue":"1","key":"728_CR274","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1386-6532(02)00128-2","volume":"27","author":"T Andrieu","year":"2003","unstructured":"Andrieu T et al (2003) Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections. J Clin Virol 27(1):59\u201368","journal-title":"J Clin Virol"},{"issue":"4","key":"728_CR275","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0168-8278(99)80211-6","volume":"30","author":"PL Lakatos","year":"1999","unstructured":"Lakatos PL et al (1999) Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in patients with primary biliary cirrhosis. J Hepatol 30(4):740","journal-title":"J Hepatol"},{"issue":"4","key":"728_CR276","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S1665-2681(19)31905-2","volume":"6","author":"YH Balaban","year":"2007","unstructured":"Balaban YH et al (2007) Dipeptidyl peptidase IV (DDP IV) in NASH patients. Ann Hepatol 6(4):242\u2013250","journal-title":"Ann Hepatol"},{"issue":"5","key":"728_CR277","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1046\/j.1464-5491.2000.00236.x","volume":"17","author":"GS Meneilly","year":"2000","unstructured":"Meneilly GS et al (2000) Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med 17(5):346\u2013350","journal-title":"Diabet Med"},{"issue":"6","key":"728_CR278","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s00125-005-1749-8","volume":"48","author":"E Mannucci","year":"2005","unstructured":"Mannucci E et al (2005) Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia 48(6):1168\u20131172","journal-title":"Diabetologia"},{"issue":"10","key":"728_CR279","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/003655201750422675","volume":"36","author":"M Hildebrandt","year":"2001","unstructured":"Hildebrandt M et al (2001) Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease. Scand J Gastroenterol 36(10):1067\u20131072","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"728_CR280","doi-asserted-by":"crossref","first-page":"R1057","DOI":"10.1152\/ajpregu.2000.278.4.R1057","volume":"278","author":"Q Xiao","year":"2000","unstructured":"Xiao Q et al (2000) Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease. Am J Physiol Regul Integr Comp Physiol 278(4):R1057\u2013R1063","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"728_CR281","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004836-200201000-00008","volume":"34","author":"M Rose","year":"2002","unstructured":"Rose M et al (2002) T-cell immune parameters and depression in patients with Crohn\u2019s disease. J Clin Gastroenterol 34(1):40\u201348","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"728_CR282","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1046\/j.1365-2222.1999.00550.x","volume":"29","author":"VH Velden van der","year":"1999","unstructured":"van der Velden VH et al (1999) Peptidase activities in serum and bronchoalveolar lavage fluid from allergic asthmatics\u2014comparison with healthy non-smokers and smokers and effects of inhaled glucocorticoids. Clin Exp Allergy 29(6):813\u2013823","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"728_CR283","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.peptides.2006.11.014","volume":"28","author":"B Jarmo\u0142owska","year":"2007","unstructured":"Jarmo\u0142owska B et al (2007) Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy. Peptides 28(3):678\u2013682","journal-title":"Peptides"},{"issue":"1","key":"728_CR284","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MPG.0b013e318054b085","volume":"45","author":"D Detel","year":"2007","unstructured":"Detel D, Persi\u0107 M, Varljen J (2007) Serum and intestinal dipeptidyl peptidase IV (DPP IV\/CD26) activity in children with celiac disease. J Pediatr Gastroenterol Nutr 45(1):65\u201370","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"728_CR285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0741-8329(98)00022-6","volume":"17","author":"M Maes","year":"1999","unstructured":"Maes M et al (1999) Lower activity of serum peptidases in abstinent alcohol-dependent patients. Alcohol 17(1):1\u20136","journal-title":"Alcohol"},{"issue":"5","key":"728_CR286","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0306-4530(98)00020-1","volume":"23","author":"M Maes","year":"1998","unstructured":"Maes M et al (1998) Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety. Psychoneuroendocrinology 23(5):485\u2013495","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"728_CR287","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0306-4530(96)00040-6","volume":"22","author":"M Maes","year":"1997","unstructured":"Maes M et al (1997) Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers. Psychoneuroendocrinology 22(2):65\u201378","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"728_CR288","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1996.tb10612.x","volume":"93","author":"M Maes","year":"1996","unstructured":"Maes M et al (1996) Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Acta Psychiatr Scand 93(1):1\u20138","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"728_CR289","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0306-4530(99)00039-6","volume":"24","author":"S Elg\u00fcn","year":"1999","unstructured":"Elg\u00fcn S, Keskinege A, Kumbasar H (1999) Dipeptidyl peptidase IV and adenosine deaminase activity decrease in depression. Psychoneuroendocrinology 24(8):823\u2013832","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"728_CR290","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-3083.1999.00612.x","volume":"50","author":"M Hildebrandt","year":"1999","unstructured":"Hildebrandt M et al (1999) Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders. Scand J Immunol 50(5):536\u2013541","journal-title":"Scand J Immunol"},{"issue":"2","key":"728_CR291","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s004060070040","volume":"250","author":"D West van","year":"2000","unstructured":"van West D et al (2000) Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa. Eur Arch Psychiatry Clin Neurosci 250(2):86\u201392","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"728_CR292","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1258\/000456307779595931","volume":"44","author":"P Vlahovi\u0107","year":"2007","unstructured":"Vlahovi\u0107 P et al (2007) Elevated serum dipeptidyl peptidase IV activity in patients with chronic tonsillitis. Ann Clin Biochem 44(1):70\u201374","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"728_CR293","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0167-5699(97)84661-0","volume":"18","author":"HJ Gruss","year":"1997","unstructured":"Gruss HJ et al (1997) Hodgkin\u2019s disease: a tumor with disturbed immunological pathways. Immunol Today 18(4):156\u2013163","journal-title":"Immunol Today"},{"issue":"4","key":"728_CR294","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1515\/bchm3.1990.371.1.325","volume":"371","author":"T Chikuma","year":"1990","unstructured":"Chikuma T et al (1990) Purification and properties of dipeptidyl peptidase IV from human urine. Biol Chem Hoppe Seyler 371(4):325\u2013330","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"2","key":"728_CR295","first-page":"145","volume":"56","author":"W Haacke","year":"1986","unstructured":"Haacke W, K\u00fcllertz G, Barth A (1986) Diagnostic value of the enzyme dipeptidyl peptidase IV (DP IV) in abdominal cancers. Arch Geschwulstforsch 56(2):145\u2013153","journal-title":"Arch Geschwulstforsch"},{"issue":"2","key":"728_CR296","first-page":"52","volume":"45","author":"G K\u00fcllertz","year":"1986","unstructured":"K\u00fcllertz G, Boigk J (1986) Dipeptidyl peptidase IV activity in the serum and synovia of patients with rheumatoid arthritis. Z Rheumatol 45(2):52\u201356","journal-title":"Z Rheumatol"},{"issue":"8","key":"728_CR297","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1515\/CCLM.1999.126","volume":"37","author":"S Elg\u00fcn","year":"1999","unstructured":"Elg\u00fcn S et al (1999) Serum dipeptidyl peptidase IV activity correlates with the T-cell CD26 antigen. Clin Chem Lab Med 37(8):839\u2013840","journal-title":"Clin Chem Lab Med"},{"issue":"51","key":"728_CR298","first-page":"1579","volume":"124","author":"A Sedo","year":"1985","unstructured":"Sedo A, H\u00e1tle K, Stolba P (1985) Changes in dipeptidyl-peptidase IV activity in human serum in pathological conditions of the thyroid gland. Cas Lek Cesk 124(51):1579\u20131581","journal-title":"Cas Lek Cesk"},{"issue":"4","key":"728_CR299","first-page":"334","volume":"32","author":"E Krepela","year":"1983","unstructured":"Krepela E et al (1983) An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-l-proline-1-naphthylamide and other glycyl-l-proline-arylamides as substrates. Physiol Bohemoslov 32(4):334\u2013345","journal-title":"Physiol Bohemoslov"},{"issue":"2","key":"728_CR300","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0012-1606(91)90076-F","volume":"143","author":"JR Bartles","year":"1991","unstructured":"Bartles JR et al (1991) Decreases in the relative concentrations of specific hepatocyte plasma membrane proteins during liver regeneration: down-regulation or dilution? Dev Biol 143(2):258\u2013270","journal-title":"Dev Biol"},{"issue":"1","key":"728_CR301","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1242\/jcs.98.1.45","volume":"98","author":"JR Bartles","year":"1991","unstructured":"Bartles JR et al (1991) Expression and compartmentalization of integral plasma membrane proteins by hepatocytes and their progenitors in the rat pancreas. J Cell Sci 98(1):45\u201354","journal-title":"J Cell Sci"},{"issue":"4","key":"728_CR302","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.1840110403","volume":"11","author":"GW McCaughan","year":"1990","unstructured":"McCaughan GW et al (1990) Identification of the bile canalicular cell surface molecule GP110 as the ectopeptidase dipeptidyl peptidase IV: an analysis by tissue distribution, purification and N-terminal amino acid sequence. Hepatology 11(4):534\u2013544","journal-title":"Hepatology"},{"key":"728_CR303","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1034\/j.1600-0528.2002.017420.x","volume":"174","author":"GW McCaughan","year":"2000","unstructured":"McCaughan GW et al (2000) Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 174:172\u2013191","journal-title":"Immunol Rev"},{"issue":"4","key":"728_CR304","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF02235759","volume":"41","author":"RJ O\u2019Hara","year":"1998","unstructured":"O\u2019Hara RJ et al (1998) Impaired interleukin-12 production is associated with a defective anti-tumour response in colorectal cancer. Dis Colon Rectum 41(4):460\u2013463","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"728_CR305","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0171-2985(97)80084-8","volume":"197","author":"OJ Cordero","year":"1997","unstructured":"Cordero OJ et al (1997) Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes. Immunobiology 197(5):522\u2013533","journal-title":"Immunobiology"},{"issue":"3","key":"728_CR306","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0009-8981(84)90275-4","volume":"139","author":"Y Kasahara","year":"1984","unstructured":"Kasahara Y et al (1984) Glycylprolyl-diaminopeptidase in human leukocytes: selective occurrence in T lymphocytes and influence on the total serum enzyme activity. Clin Chim Acta 139(3):295\u2013302","journal-title":"Clin Chim Acta"},{"issue":"20","key":"728_CR307","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/0006-2952(84)90075-3","volume":"33","author":"PE Ward","year":"1984","unstructured":"Ward PE (1984) Immunoelectrophoretic analysis of vascular, membrane-bound angiotensin I converting enzyme, aminopeptidase M, and dipeptidyl(amino) peptidase IV. Biochem Pharmacol 33(20):3183\u20133193","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"728_CR308","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/44.5.8627002","volume":"44","author":"S Mentzel","year":"1996","unstructured":"Mentzel S et al (1996) Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J Histochem Cytochem 44(5):445\u2013461","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"728_CR309","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00495663","volume":"59","author":"Z Lojda","year":"1979","unstructured":"Lojda Z (1979) Studies on dipeptidyl(amino)peptidase IV (glycyl-proline naphthylamidase). II. Blood vessels. Histochemistry 59(3):153\u2013166","journal-title":"Histochemistry"},{"issue":"1","key":"728_CR310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2222.1998.00198.x","volume":"28","author":"V Velden van der","year":"1998","unstructured":"van der Velden V et al (1998) Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus. Clin Exp Allergy 28(1):110\u2013120","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"728_CR311","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00495756","volume":"60","author":"R Gossrau","year":"1979","unstructured":"Gossrau R (1979) Peptidases II. Localization of dipeptidylpeptidase IV (DPP IV). Histochemical and biochemical study. Histochemistry 60(2):231\u2013248","journal-title":"Histochemistry"},{"key":"728_CR312","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1267\/ahc.16.494","volume":"16","author":"N Sahara","year":"1983","unstructured":"Sahara N et al (1983) Immunohistochemical localization of dipeptidyl peptidase IV in rat digestive organs. Acta Histochem Cytochem 16:494\u2013501","journal-title":"Acta Histochem Cytochem"},{"issue":"1","key":"728_CR313","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbrc.2003.08.111","volume":"310","author":"L Pala","year":"2003","unstructured":"Pala L et al (2003) Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells. Biochem Biophys Res Commun 310(1):28\u201331","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"728_CR314","first-page":"2116","volume":"32","author":"JC Mavropoulos","year":"2005","unstructured":"Mavropoulos JC et al (2005) Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78\/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis. J Rheumatol 32(11):2116\u20132124","journal-title":"J Rheumatol"},{"issue":"3","key":"728_CR315","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-0714.1998.tb01924.x","volume":"27","author":"T Uematsu","year":"1998","unstructured":"Uematsu T, Urade M, Yamaoka M (1998) Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients. J Oral Pathol Med 27(3):106\u2013110","journal-title":"J Oral Pathol Med"},{"issue":"2B","key":"728_CR316","first-page":"619","volume":"24","author":"T Uematsu","year":"2004","unstructured":"Uematsu T et al (2004) Effects of oral squamous cell carcinoma-derived TGF-beta1 on CD26\/DPPIV expression in T cells. Anticancer Res 24(2B):619\u2013624","journal-title":"Anticancer Res"},{"issue":"3A Suppl","key":"728_CR317","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/29.3.481","volume":"29","author":"Z Lojda","year":"1981","unstructured":"Lojda Z (1981) Proteinases in pathology. Usefulness of histochemical methods. J Histochem Cytochem 29(3A Suppl):481\u2013493","journal-title":"J Histochem Cytochem"},{"issue":"10","key":"728_CR318","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/BF01002534","volume":"17","author":"Z Lojda","year":"1985","unstructured":"Lojda Z (1985) The importance of protease histochemistry in pathology. Histochem J 17(10):1063\u20131089","journal-title":"Histochem J"},{"issue":"4","key":"728_CR319","first-page":"181","volume":"11","author":"Z Lojda","year":"1988","unstructured":"Lojda Z (1988) Dipeptidyl peptidases of human lymphocytes. Czech Med 11(4):181\u2013194","journal-title":"Czech Med"},{"issue":"4","key":"728_CR320","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.0300-9475.2004.01406.x","volume":"59","author":"US Sehmsdorf","year":"2004","unstructured":"Sehmsdorf US et al (2004) Human miscarriage is associated with increased number of CD26 decidual lymphocytes. Scand J Immunol 59(4):400\u2013407","journal-title":"Scand J Immunol"},{"issue":"5","key":"728_CR321","first-page":"685","volume":"73","author":"D Scheel-Toellner","year":"1995","unstructured":"Scheel-Toellner D et al (1995) CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma. Lab Invest 73(5):685\u2013690","journal-title":"Lab Invest"},{"issue":"3","key":"728_CR322","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0091-6749(97)70248-3","volume":"100","author":"M Willheim","year":"1997","unstructured":"Willheim M et al (1997) Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J Allergy Clin Immunol 100(3):348\u2013355","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"728_CR323","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1523-1747.2000.00881.x","volume":"114","author":"A Cavani","year":"2000","unstructured":"Cavani A et al (2000) Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 114(2):295\u2013302","journal-title":"J Invest Dermatol"},{"issue":"1","key":"728_CR324","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH656>3.0.CO;2-M","volume":"192","author":"A M\u00fcller","year":"2000","unstructured":"M\u00fcller A et al (2000) Localized Wegener\u2019s granulomatosis: predominance of CD26 and IFN-gamma expression. J Pathol 192(1):113\u2013120","journal-title":"J Pathol"},{"issue":"9","key":"728_CR325","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1177\/002215540205000903","volume":"50","author":"EP Boonacker","year":"2002","unstructured":"Boonacker EP et al (2002) CD26\/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry. J Histochem Cytochem 50(9):1169\u20131177","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"728_CR326","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1067\/mai.2002.121457","volume":"109","author":"RP Schade","year":"2002","unstructured":"Schade RP et al (2002) Cell-surface expression of CD25, CD26, and CD30 by allergen-specific T cells is intrinsically different in cow\u2019s milk allergy. J Allergy Clin Immunol 109(2):357\u2013362","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"728_CR327","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000058395","volume":"91","author":"K Nakao","year":"2002","unstructured":"Nakao K et al (2002) Serum levels of soluble CD26 and CD30 in patients on hemodialysis. Nephron 91(2):215\u2013221","journal-title":"Nephron"},{"issue":"4","key":"728_CR328","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000096191","volume":"213","author":"MT Fierro","year":"2006","unstructured":"Fierro MT et al (2006) Expression pattern of chemokine receptors and chemokine release in inflammatory erythroderma and S\u00e9zary syndrome. Dermatology 213(4):284\u2013292","journal-title":"Dermatology"},{"issue":"1\u20132","key":"728_CR329","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2006.09.006","volume":"181","author":"M Krakauer","year":"2006","unstructured":"Krakauer M, Sorensen PS, Sellebjerg F (2006) CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis. J Neuroimmunol 181(1\u20132):157\u2013164","journal-title":"J Neuroimmunol"},{"issue":"1","key":"728_CR330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2249.2008.03666.x","volume":"153","author":"R Jafari-Shakib","year":"2008","unstructured":"Jafari-Shakib R et al (2008) CD26 expression on CD4+ T cells in patients with cutaneous leishmaniasis. Clin Exp Immunol 153(1):31\u201336","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"728_CR331","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3129\/i07-179","volume":"43","author":"F Ilhan","year":"2008","unstructured":"Ilhan F et al (2008) Th1 polarization of the immune response in uveitis in Beh\u00e7et\u2019s disease. Can J Ophthalmol 43(1):105\u2013108","journal-title":"Can J Ophthalmol"},{"issue":"5","key":"728_CR332","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/labinvest.2008.24","volume":"88","author":"Y Ma","year":"2008","unstructured":"Ma Y et al (2008) The CD4+ CD26\u2212 T-cell population in classical Hodgkin\u2019s lymphoma displays a distinctive regulatory T-cell profile. Lab Invest 88(5):482\u2013490","journal-title":"Lab Invest"},{"issue":"10","key":"728_CR333","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.190.10.1367","volume":"190","author":"C Cordon-Cardo","year":"1999","unstructured":"Cordon-Cardo C, Prives C (1999) At the crossroads of inflammation and tumorigenesis. J Exp Med 190(10):1367\u20131370","journal-title":"J Exp Med"},{"issue":"26","key":"728_CR334","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"Dvorak-HF","year":"1986","unstructured":"Dvorak-HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315(26):1650\u20131659","journal-title":"N Engl J Med"},{"issue":"12","key":"728_CR335","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1196\/annals.1322.041","volume":"1028","author":"RM Strieter","year":"2004","unstructured":"Strieter RM et al (2004) CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Ann N Y Acad Sci 1028(12):351\u2013360","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"728_CR336","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1470-2045(03)01196-3","volume":"4","author":"PW Szlosarek","year":"2003","unstructured":"Szlosarek PW, Balkwill FR (2003) Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol 4(9):565\u2013573","journal-title":"Lancet Oncol"},{"issue":"2","key":"728_CR337","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2007.04.012","volume":"120","author":"JB Byrd","year":"2007","unstructured":"Byrd JB et al (2007) Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema. J Allergy Clin Immunol 120(2):403\u2013408","journal-title":"J Allergy Clin Immunol"},{"key":"728_CR338","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.med.56.082103.104549","volume":"57","author":"TA Waldmann","year":"2006","unstructured":"Waldmann TA (2006) Effective cancer therapy through immunomodulation. Annu Rev Med 57:65\u201381","journal-title":"Annu Rev Med"},{"issue":"12","key":"728_CR339","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/nm1201-1339","volume":"7","author":"W Zou","year":"2001","unstructured":"Zou W et al (2001) Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7(12):1339\u20131346","journal-title":"Nat Med"},{"issue":"19","key":"728_CR340","first-page":"6478","volume":"63","author":"E Hartmann","year":"2003","unstructured":"Hartmann E et al (2003) Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res 63(19):6478\u20136487","journal-title":"Cancer Res"},{"issue":"9","key":"728_CR341","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942\u2013949","journal-title":"Nat Med"},{"issue":"11 Suppl","key":"728_CR342","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/jn\/131.11.3109S","volume":"131","author":"E Giovannucci","year":"2001","unstructured":"Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131(11 Suppl):3109\u20133120","journal-title":"J Nutr"},{"issue":"3","key":"728_CR343","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.regpep.2006.07.003","volume":"137","author":"K Masur","year":"2006","unstructured":"Masur K et al (2006) DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells. Regul Pept 137(3):147\u2013155","journal-title":"Regul Pept"},{"issue":"1","key":"728_CR344","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2004.09.021","volume":"324","author":"JM Lenhard","year":"2004","unstructured":"Lenhard JM, Croom DK, Minnick DT (2004) Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments. Biochem Biophys Res Commun 324(1):92\u201397","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"728_CR345","doi-asserted-by":"crossref","first-page":"R811","DOI":"10.1152\/ajpregu.00543.2007","volume":"294","author":"CH Wang","year":"2008","unstructured":"Wang CH et al (2008) Cyclosporine increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. Am J Physiol Regul Integr Comp Physiol 294(3):R811\u2013R818","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"6","key":"728_CR346","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-07-1589","volume":"68","author":"DT Dang","year":"2008","unstructured":"Dang DT et al (2008) Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Cancer Res 68(6):1872\u20131880","journal-title":"Cancer Res"},{"issue":"3","key":"728_CR347","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0196-9781(01)00340-0","volume":"22","author":"G Ghersi","year":"2001","unstructured":"Ghersi G et al (2001) Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 22(3):453\u2013458","journal-title":"Peptides"},{"issue":"12","key":"728_CR348","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1200\/JCO.2007.14.5193","volume":"26","author":"JA Thompson","year":"2008","unstructured":"Thompson JA et al (2008) Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma. J Clin Oncol 26(12):2034\u20132039","journal-title":"J Clin Oncol"},{"key":"728_CR349","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.immunol.021908.132544","volume":"27","author":"M Dougan","year":"2009","unstructured":"Dougan M, Dranoff G (2009) Immune therapy for cancer. Annu Rev Immunol 27:83\u2013117","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"728_CR350","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1158\/0008-5472.CAN-07-3040","volume":"68","author":"CE Rolle","year":"2008","unstructured":"Rolle CE, Carrio R, Malek TR (2008) Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy. Cancer Res 68(8):2984\u20132992","journal-title":"Cancer Res"},{"issue":"1","key":"728_CR351","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/cncr.24013","volume":"115","author":"X Duan","year":"2009","unstructured":"Duan X et al (2009) Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors. Cancer 115(1):13\u201322","journal-title":"Cancer"},{"issue":"5","key":"728_CR352","first-page":"329","volume":"4","author":"S Park","year":"2007","unstructured":"Park S, Cheon S, Cho D (2007) The dual effects of interleukin-18 in tumor progression. Cell Mol Immunol 4(5):329\u2013335","journal-title":"Cell Mol Immunol"},{"key":"728_CR353","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.2741\/2884","volume":"13","author":"S Mocellin","year":"2008","unstructured":"Mocellin S, Nitti D (2008) TNF and cancer: the two sides of the coin. Front Biosci 13:2774\u20132783","journal-title":"Front Biosci"},{"issue":"1","key":"728_CR354","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2004.11.001","volume":"16","author":"S Mocellin","year":"2005","unstructured":"Mocellin S et al (2005) Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 16(1):35\u201353","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0728-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-009-0728-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-009-0728-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T19:56:40Z","timestamp":1685044600000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-009-0728-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,26]]},"references-count":354,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s00262-009-0728-1","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,26]]}}}